(The TQCC of
Arteriosclerosis Thrombosis and Vascular Biology is
88. The table below lists those papers that are above that threshold based on
CrossRef citation counts. The publications cover those that have been published in the past four years, i.e., from 2019-03-01 to 2023-03-01.)
Article | Citations |
---|
Lessons From Sudden Coronary Death | 2842 |
Plasma Concentrations of a Novel, Adipose-Specific Protein, Adiponectin, in Type 2 Diabetic Patients | 2225 |
C-Reactive Protein in Healthy Subjects: Associations With Obesity, Insulin Resistance, and Endothelial Dysfunction | 1664 |
Endothelial Dysfunction | 1535 |
Mechanisms, Pathophysiology, and Therapy of Arterial Stiffness | 1162 |
Association of Hypoadiponectinemia With Coronary Artery Disease in Men | 1049 |
Atherosclerotic Plaque Progression and Vulnerability to Rupture | 1008 |
Obesity and Systemic Oxidative Stress | 1002 |
Is Oxidative Stress the Pathogenic Mechanism Underlying Insulin Resistance, Diabetes, and Cardiovascular Disease? The Common Soil Hypothesis Revisited | 929 |
Characterization of Two Types of Endothelial Progenitor Cells and Their Different Contributions to Neovasculogenesis | 914 |
The Response-to-Retention Hypothesis of Early Atherogenesis | 909 |
Adiponectin and Metabolic Syndrome | 853 |
Oxidative Stress and Vascular Disease | 847 |
A Paracrine Loop Between Adipocytes and Macrophages Aggravates Inflammatory Changes | 801 |
Laminar Shear Stress | 765 |
A Definition of Advanced Types of Atherosclerotic Lesions and a Histological Classification of Atherosclerosis | 725 |
Vascular Calcification | 663 |
Brain Cholesterol: Long Secret Life Behind a Barrier | 656 |
Modulation of Protein Kinase Activity and Gene Expression by Reactive Oxygen Species and Their Role in Vascular Physiology and Pathophysiology | 648 |
Cholesteryl Ester Transfer Protein | 628 |
Role of the Toll-like Receptor 4/NF-κB Pathway in Saturated Fatty Acid–Induced Inflammatory Changes in the Interaction Between Adipocytes and Macrophages | 619 |
Noninvasive Assessment of Arterial Stiffness and Risk of Atherosclerotic Events | 587 |
Ankle-Arm Index as a Predictor of Cardiovascular Disease and Mortality in the Cardiovascular Health Study | 571 |
Endothelial Progenitor Cells | 562 |
Myeloperoxidase and Cardiovascular Disease | 551 |
Lack of Interleukin-1β Decreases the Severity of Atherosclerosis in ApoE-Deficient Mice | 543 |
Paraoxonase and Atherosclerosis | 541 |
High-Density Lipoproteins Inhibit Cytokine-Induced Expression of Endothelial Cell Adhesion Molecules | 533 |
Upregulation of VCAM-1 and ICAM-1 at Atherosclerosis-Prone Sites on the Endothelium in the ApoE-Deficient Mouse | 532 |
Obesity and Cardiovascular Disease | 526 |
Relationship of C-Reactive Protein to Risk of Cardiovascular Disease in the Elderly | 522 |
Consequences and Therapeutic Implications of Macrophage Apoptosis in Atherosclerosis | 510 |
High Density Lipoproteins and Arteriosclerosis | 502 |
Natural History and Histological Classification of Atherosclerotic Lesions | 495 |
Reactive Oxygen Species Activate the HIF-1α Promoter Via a Functional NFκB Site | 478 |
Statins Upregulate
PCSK9
, the Gene Encoding the Proprotein Convertase Neural Apoptosis-Regulated Convertase-1 Implicated in Familial Hypercholesterolemia | 477 |
Peripheral Arterial Disease in the Elderly | 472 |
Inflammation and Matrix Metalloproteinases in the Enlarging Abdominal Aortic Aneurysm | 468 |
Platelets and Thrombin Generation | 462 |
Inflammation and Cellular Immune Responses in Abdominal Aortic Aneurysms | 462 |
Olive Oil and Red Wine Antioxidant Polyphenols Inhibit Endothelial Activation | 461 |
Distinct Subcellular Localizations of Nox1 and Nox4 in Vascular Smooth Muscle Cells | 456 |
Novel Autologous Cell Therapy in Ischemic Limb Disease Through Growth Factor Secretion by Cultured Adipose Tissue–Derived Stromal Cells | 455 |
Inflammation and Restenosis in the Stent Era | 453 |
The Yin and Yang of Oxidation in the Development of the Fatty Streak | 451 |
White Cell Telomere Length and Risk of Premature Myocardial Infarction | 446 |
Abdominal Aortic Aneurysm | 442 |
Vascular Inflammation and the Renin-Angiotensin System | 437 |
Nuclear Factor κB Signaling in Atherogenesis | 437 |
Omega-3 Fatty Acids and Cardiovascular Disease | 437 |
Asymmetric Dimethylarginine Causes Hypertension and Cardiac Dysfunction in Humans and Is Actively Metabolized by Dimethylarginine Dimethylaminohydrolase | 435 |
Site Specificity of Atherosclerosis | 426 |
Role of Tissue Factor in Hemostasis, Thrombosis, and Vascular Development | 425 |
Lipid Oxidation Products Have Opposite Effects on Calcifying Vascular Cell and Bone Cell Differentiation | 424 |
Cardiovascular Biology of the Asymmetric Dimethylarginine:Dimethylarginine Dimethylaminohydrolase Pathway | 413 |
Quantitative Evaluation of Carotid Plaque Composition by In Vivo MRI | 410 |
Osteo/Chondrocytic Transcription Factors and Their Target Genes Exhibit Distinct Patterns of Expression in Human Arterial Calcification | 398 |
Gamma Glutamyl Transferase and Metabolic Syndrome, Cardiovascular Disease, and Mortality Risk | 398 |
Definition of Metabolic Syndrome | 395 |
Reduced Progression of Atherosclerosis in Apolipoprotein E–Deficient Mice Following Consumption of Red Wine, or Its Polyphenols Quercetin or Catechin, Is Associated With Reduced Susceptibility of LDL | 394 |
Expression, Regulation, and Function of IGF-1, IGF-1R, and IGF-1 Binding Proteins in Blood Vessels | 392 |
Importance of Different Pathways of Cellular Cholesterol Efflux | 392 |
Morphologic Findings of Coronary Atherosclerotic Plaques in Diabetics | 392 |
Medial Artery Calcification | 389 |
Regulation of Endothelial Nitric Oxide Synthase by Tetrahydrobiopterin in Vascular Disease | 386 |
Does ADMA Cause Endothelial Dysfunction? | 383 |
Scavenger Receptors in Atherosclerosis | 382 |
Rho-Kinase Is an Important Therapeutic Target in Cardiovascular Medicine | 381 |
Elevated C-Reactive Protein | 380 |
Role of ApoCs in Lipoprotein Metabolism | 377 |
The Dynamics of Thrombin Formation | 376 |
Platelets in Inflammation and Thrombosis | 371 |
Formation of Hyaluronan- and Versican-Rich Pericellular Matrix Is Required for Proliferation and Migration of Vascular Smooth Muscle Cells | 370 |
Apolipoprotein E Alleles and Risk of Coronary Disease | 369 |
Apolipoproteins B, (a), and E Accumulate in the Morphologically Early Lesion of ‘Degenerative’ Valvular Aortic Stenosis | 368 |
Mouse Models of Abdominal Aortic Aneurysms | 367 |
Inhibition of Tumor Necrosis Factor-α Reduces Atherosclerosis in Apolipoprotein E Knockout Mice | 366 |
Role of Lipoprotein-Associated Phospholipase A
2
in Atherosclerosis | 365 |
Interleukin-6 Exacerbates Early Atherosclerosis in Mice | 364 |
Vascular Protection | 363 |
Improvement of Nitric Oxide–Dependent Vasodilatation by HMG-CoA Reductase Inhibitors Through Attenuation of Endothelial Superoxide Anion Formation | 362 |
Endothelium-Derived Hyperpolarizing Factor | 361 |
Atherosclerosis in the Apolipoprotein E–Deficient Mouse | 358 |
Quantification of Isoprostanes as Indices of Oxidant Stress and the Risk of Atherosclerosis in Humans | 358 |
Warfarin Causes Rapid Calcification of the Elastic Lamellae in Rat Arteries and Heart Valves | 358 |
C-Reactive Protein in the Arterial Intima | 357 |
Angiotensin II Stimulates Endothelial Vascular Cell Adhesion Molecule-1 via Nuclear Factor-κB Activation Induced by Intracellular Oxidative Stress | 356 |
Heterogeneity of Endothelial Cells | 355 |
Metformin Inhibits Proinflammatory Responses and Nuclear Factor-κB in Human Vascular Wall Cells | 351 |
Circulating Oxidized LDL Is a Useful Marker for Identifying Patients With Coronary Artery Disease | 347 |
The Farnesoid X Receptor | 346 |
Evidence for Association Between Polycystic Ovary Syndrome and Premature Carotid Atherosclerosis in Middle-Aged Women | 346 |
Influence of Fibrin Network Conformation and Fibrin Fiber Diameter on Fibrinolysis Speed | 343 |
Bone Marrow–Derived Progenitor Cells Modulate Vascular Reendothelialization and Neointimal Formation | 342 |
Lifetime Smoking Exposure Affects the Association of C-Reactive Protein with Cardiovascular Disease Risk Factors and Subclinical Disease in Healthy Elderly Subjects | 341 |
Procoagulant Microparticles | 340 |
Isoprostanes: Potential Markers of Oxidant Stress in Atherothrombotic Disease | 339 |
Coronary Heart Disease Risk Factors in Women With Polycystic Ovary Syndrome | 338 |
HMG-CoA Reductase Inhibitors Reduce MMP-9 Secretion by Macrophages | 336 |
Paraoxonase Active Site Required for Protection Against LDL Oxidation Involves Its Free Sulfhydryl Group and Is Different From That Required for Its Arylesterase/Paraoxonase Activities | 336 |
Phagocytosis of Apoptotic Cells by Macrophages Is Impaired in Atherosclerosis | 334 |
Associations of C-Reactive Protein With Measures of Obesity, Insulin Resistance, and Subclinical Atherosclerosis in Healthy, Middle-Aged Women | 332 |
Number and Function of Endothelial Progenitor Cells as a Marker of Severity for Diabetic Vasculopathy | 331 |
Aortic Dissection Precedes Formation of Aneurysms and Atherosclerosis in Angiotensin II-Infused, Apolipoprotein E-Deficient Mice | 329 |
Smoking Cessation Rapidly Increases Circulating Progenitor Cells in Peripheral Blood in Chronic Smokers | 326 |
ABCA1 and ABCG1 Synergize to Mediate Cholesterol Export to ApoA-I | 325 |
Matrix Metalloproteinase-9 (MMP-9), MMP-2, and Serum Elastase Activity Are Associated With Systolic Hypertension and Arterial Stiffness | 324 |
The Unstable Atheroma | 321 |
C-Reactive Protein Frequently Colocalizes With the Terminal Complement Complex in the Intima of Early Atherosclerotic Lesions of Human Coronary Arteries | 321 |
Absence of Age-Related Increase in Central Arterial Stiffness in Physically Active Women | 319 |
Soy Isoflavones Improve Systemic Arterial Compliance but Not Plasma Lipids in Menopausal and Perimenopausal Women | 319 |
Hypochlorous Acid, a Macrophage Product, Induces Endothelial Apoptosis and Tissue Factor Expression | 318 |
Human Atherosclerotic Plaque Contains Viable Invasive
Actinobacillus actinomycetemcomitans
and
Porphyromonas gingivalis | 317 |
Small, Dense HDL Particles Exert Potent Protection of Atherogenic LDL Against Oxidative Stress | 316 |
Raising High-Density Lipoprotein in Humans Through Inhibition of Cholesteryl Ester Transfer Protein | 316 |
Endothelial α
ν
β
3
Integrin–Targeted Fumagillin Nanoparticles Inhibit Angiogenesis in Atherosclerosis | 315 |
Increased Atherosclerosis in Hyperlipidemic Mice With Inactivation of ABCA1 in Macrophages | 313 |
Statin Safety and Associated Adverse Events: A Scientific Statement From the American Heart Association | 313 |
Aspirin and Clopidogrel | 312 |
Interrelationships Among Circulating Interleukin-6, C-Reactive Protein, and Traditional Cardiovascular Risk Factors in Women | 312 |
Dysfunction of Endothelial Nitric Oxide Synthase and Atherosclerosis | 311 |
Shear-Induced Platelet Activation and Platelet Microparticle Formation at Blood Flow Conditions as in Arteries With a Severe Stenosis | 311 |
Interactions of Oxidants With Vascular Signaling Systems | 307 |
Oxidized LDL in Carotid Plaques and Plasma Associates With Plaque Instability | 306 |
Pleiotropic Actions of Peroxisome Proliferator–Activated Receptors in Lipid Metabolism and Atherosclerosis | 306 |
Low-Density Lipoprotein Subfractions and the Long-Term Risk of Ischemic Heart Disease in Men | 304 |
Monocyte Chemoattractant Protein-1 Accelerates Atherosclerosis in Apolipoprotein E-Deficient Mice | 303 |
Reduction of LDL Cholesterol by 25% to 60% in Patients With Primary Hypercholesterolemia by Atorvastatin, a New HMG-CoA Reductase Inhibitor | 303 |
Signal Transduction Pathways Mediated by PECAM-1 | 302 |
Pericellular Proteases in Angiogenesis and Vasculogenesis | 301 |
A Comparison of Three Different Methods to Evaluate Endothelium-Dependent Vasodilation in the Elderly | 301 |
Expression of Multiple Isoforms of Nitric Oxide Synthase in Normal and Atherosclerotic Vessels | 298 |
Angiotensin Induces Inflammatory Activation of Human Vascular Smooth Muscle Cells | 296 |
Arterial Smooth Muscle Cell Heterogeneity | 295 |
HDL and the Inflammatory Response Induced by LDL-Derived Oxidized Phospholipids | 295 |
Notch Signaling in Vascular Development | 292 |
Endothelium-Dependent Effects of Statins | 290 |
Oral Infection With a Periodontal Pathogen Accelerates Early Atherosclerosis in Apolipoprotein E–Null Mice | 289 |
RANK Ligand and Osteoprotegerin | 288 |
Remodeling With Neointima Formation in the Mouse Carotid Artery After Cessation of Blood Flow | 287 |
Platelet Microparticles | 287 |
Patterns and Risk Factors for Systemic Calcified Atherosclerosis | 286 |
Production of Chemokines by Perivascular Adipose Tissue | 286 |
Biomarkers of Atherosclerotic Plaque Instability and Rupture | 285 |
Lysosomal Cysteine Proteases in Atherosclerosis | 285 |
Plasma Levels of Soluble Receptor for Advanced Glycation End Products and Coronary Artery Disease in Nondiabetic Men | 283 |
Circulating Oxidized Low Density Lipoprotein Levels | 282 |
Association of Cholesteryl Ester Transfer Protein–
Taq
IB Polymorphism With Variations in Lipoprotein Subclasses and Coronary Heart Disease Risk | 282 |
Caveolin, Caveolae, and Endothelial Cell Function | 281 |
The Unfolded Protein Response Is an Important Regulator of Inflammatory Genes in Endothelial Cells | 281 |
Simvastatin Reduces Expression of Cytokines Interleukin-6, Interleukin-8, and Monocyte Chemoattractant Protein-1 in Circulating Monocytes From Hypercholesterolemic Patients | 280 |
Race, Visceral Adipose Tissue, Plasma Lipids, and Lipoprotein Lipase Activity in Men and Women | 279 |
Urinary Albumin Excretion | 277 |
Regulation of Superoxide Anion Production by NADPH Oxidase in Monocytes/Macrophages | 276 |
Molecular Mechanisms of Vascular Calcification | 276 |
Vascular Consequences of Endothelial Nitric Oxide Synthase Uncoupling for the Activity and Expression of the Soluble Guanylyl Cyclase and the cGMP-Dependent Protein Kinase | 275 |
Serum Paraoxonase Activity, Concentration, and Phenotype Distribution in Diabetes Mellitus and Its Relationship to Serum Lipids and Lipoproteins | 274 |
The Effect of α-Tocopherol Supplementation on LDL Oxidation | 272 |
Plasma Sphingomyelin Level as a Risk Factor for Coronary Artery Disease | 272 |
Impact of Weight Loss on Inflammatory Proteins and Their Association With the Insulin Resistance Syndrome in Morbidly Obese Patients | 272 |
Periodontal Disease Is Associated With Brachial Artery Endothelial Dysfunction and Systemic Inflammation | 270 |
Peroxisome Proliferator–Activated Receptor Activators Target Human Endothelial Cells to Inhibit Leukocyte–Endothelial Cell Interaction | 270 |
C-Reactive Protein Is Associated With Arterial Stiffness in Apparently Healthy Individuals | 269 |
Endothelial Cell Glycocalyx Modulates Immobilization of Leukocytes at the Endothelial Surface | 267 |
Interleukin-10 Blocks Atherosclerotic Events In Vitro and In Vivo | 267 |
What Does It Take to Make the Perfect Clot? | 266 |
Lipoprotein Heterogeneity and Apolipoprotein B Metabolism | 265 |
Effects of Serum Lipoproteins and Smoking on Atherosclerosis in Young Men and Women | 265 |
Nonalcoholic Fatty Liver Disease Is Associated With Carotid Atherosclerosis | 264 |
Medroxyprogesterone Acetate Antagonizes Inhibitory Effects of Conjugated Equine Estrogens on Coronary Artery Atherosclerosis | 264 |
Inhibition of Rho-Kinase Leads to Rapid Activation of Phosphatidylinositol 3-Kinase/Protein Kinase Akt and Cardiovascular Protection | 264 |
Oxidation of LDL by Myeloperoxidase and Reactive Nitrogen Species | 263 |
Isolated Low HDL Cholesterol As a Risk Factor for Coronary Heart Disease Mortality | 262 |
Higher Serum Bilirubin Is Associated With Decreased Risk for Early Familial Coronary Artery Disease | 262 |
HMG-CoA Reductase Inhibitors Regulate Inflammatory Transcription Factors in Human Endothelial and Vascular Smooth Muscle Cells | 262 |
Reactive Oxygen Species | 261 |
Fish Consumption, Fish Oil, Omega-3 Fatty Acids, and Cardiovascular Disease | 261 |
Apoptosis of Vascular Smooth Muscle Cells Induced by In Vitro Stimulation With Interferon-γ, Tumor Necrosis Factor–α, and Interleukin-1β | 261 |
Troglitazone Inhibits Formation of Early Atherosclerotic Lesions in Diabetic and Nondiabetic Low Density Lipoprotein Receptor–Deficient Mice | 261 |
Simvastatin Has Anti-Inflammatory and Antiatherosclerotic Activities Independent of Plasma Cholesterol Lowering | 261 |
Vascular Endothelial Cells Respond to Spatial Gradients in Fluid Shear Stress by Enhanced Activation of Transcription Factors | 259 |
Identifying Inflamed Carotid Plaques Using In Vivo USPIO-Enhanced MR Imaging to Label Plaque Macrophages | 259 |
PAI-1 and the Metabolic Syndrome | 258 |
Progression of Aortic Calcification Is Associated With Metacarpal Bone Loss During Menopause | 258 |
C-Reactive Protein, Interleukin-6, and Fibrinogen as Predictors of Coronary Heart Disease | 257 |
Thrombomodulin-Protein C-EPCR System | 256 |
Associations Between Cardiorespiratory Fitness and C-Reactive Protein in Men | 256 |
Role of Naturally Occurring CD4
+
CD25
+
Regulatory T Cells in Experimental Atherosclerosis | 256 |
Common Promoter Variant in Cyclooxygenase-2 Represses Gene Expression | 256 |
Associations of Coronary Heart Disease Risk Factors With the Intermediate Lesion of Atherosclerosis in Youth | 256 |
Increase of Circulating Endothelial Progenitor Cells in Patients with Coronary Artery Disease After Exercise-Induced Ischemia | 255 |
Metabolic Cardiovascular Syndrome and Risk of Dementia in Japanese-American Elderly Men | 255 |
Dynamics and Plasticity of Weibel-Palade Bodies in Endothelial Cells | 254 |
The Interstitium of the Human Arterial Wall Contains Very Large Amounts of Extracellular Superoxide Dismutase | 254 |
Statins Inhibit Secretion of Metalloproteinases-1, -2, -3, and -9 From Vascular Smooth Muscle Cells and Macrophages | 253 |
PPARγ Activation in Human Endothelial Cells Increases Plasminogen Activator Inhibitor Type-1 Expression | 253 |
Lipoprotein-Associated Phospholipase A
2
Protein Expression in the Natural Progression of Human Coronary Atherosclerosis | 253 |
Nox4 Is Required for Maintenance of the Differentiated Vascular Smooth Muscle Cell Phenotype | 252 |
Altered Fibrin Architecture Is Associated With Hypofibrinolysis and Premature Coronary Atherothrombosis | 252 |
In Vivo Formation of 8-Epi-Prostaglandin F
2α
Is Increased in Hypercholesterolemia | 252 |
Flow Effects on Coagulation and Thrombosis | 251 |
Decreased Number and Impaired Angiogenic Function of Endothelial Progenitor Cells in Patients With Chronic Renal Failure | 251 |
NO Generation From Nitrite and Its Role in Vascular Control | 250 |
Evidence for a Functional Role of Endothelial Transient Receptor Potential V4 in Shear Stress–Induced Vasodilatation | 250 |
B-Lymphocyte Deficiency Increases Atherosclerosis in LDL Receptor–Null Mice | 249 |
Role of JNK, p38, and ERK in Platelet-Derived Growth Factor–Induced Vascular Proliferation, Migration, and Gene Expression | 249 |
Strong Induction of Members of the Chitinase Family of Proteins in Atherosclerosis | 249 |
Transforming Growth Factor-β Mediates Balance Between Inflammation and Fibrosis During Plaque Progression | 248 |
Effects of Oral and Transdermal Estrogen/Progesterone Regimens on Blood Coagulation and Fibrinolysis in Postmenopausal Women | 248 |
Hyperhomocysteinemia Is Associated With an Increased Risk of Cardiovascular Disease, Especially in Non–Insulin-Dependent Diabetes Mellitus | 248 |
Redox Mechanisms in Blood Vessels | 247 |
Summary of American Heart Association Diet and Lifestyle Recommendations Revision 2006 | 247 |
Presence of Oxidized Low Density Lipoprotein in Nonrheumatic Stenotic Aortic Valves | 246 |
Circulating Oxidized LDL Is Associated With Subclinical Atherosclerosis Development and Inflammatory Cytokines (AIR Study) | 246 |
Progression of Coronary Artery Calcium and Risk of First Myocardial Infarction in Patients Receiving Cholesterol-Lowering Therapy | 246 |
Factors Regulating Arteriogenesis | 245 |
Human Atherosclerotic Plaque Contains Both Oxidized Lipids and Relatively Large Amounts of α-Tocopherol and Ascorbate | 245 |
Upregulation of Endothelial Receptor for Oxidized LDL (LOX-1) by Oxidized LDL and Implications in Apoptosis of Human Coronary Artery Endothelial Cells | 245 |
Role of Oxidative Stress in the Pathogenesis of Abdominal Aortic Aneurysms | 244 |
Sensitivity and Specificity of the Ankle–Brachial Index to Predict Future Cardiovascular Outcomes | 244 |
Dose-Response Relationship Between Ischemic Heart Disease Mortality and Long-term Arsenic Exposure | 244 |
Plasma Level of Endogenous Secretory RAGE Is Associated With Components of the Metabolic Syndrome and Atherosclerosis | 244 |
Role of Heat Shock Proteins in Atherosclerosis | 243 |
Circulating CD31
+
/Annexin V
+
Apoptotic Microparticles Correlate With Coronary Endothelial Function in Patients With Coronary Ar | 243 |
Role of NO in Flow-Induced Remodeling of the Rabbit Common Carotid Artery | 242 |
Expression of Neutrophil Gelatinase–Associated Lipocalin in Atherosclerosis and Myocardial Infarction | 242 |
Reduced Vascular Remodeling, Endothelial Dysfunction, and Oxidative Stress in Resistance Arteries of Angiotensin II–Infused Macrophage Colony-Stimulating Factor–Deficient Mice | 242 |
Relation of Lipoprotein Subclasses as Measured by Proton Nuclear Magnetic Resonance Spectroscopy to Coronary Artery Disease | 241 |
Microalbuminuria and Peripheral Arterial Disease Are Independent Predictors of Cardiovascular and All-Cause Mortality, Especially Among Hypertensive Subjects | 241 |
Gene Transfer and Hepatic Overexpression of the HDL Receptor SR-BI Reduces Atherosclerosis in the Cholesterol-Fed LDL Receptor–Deficient Mouse | 240 |
Insulin Resistance Syndrome Predicts the Risk of Coronary Heart Disease and Stroke in Healthy Middle-Aged Men | 240 |
Free Fatty Acid Impairment of Nitric Oxide Production in Endothelial Cells Is Mediated by IKKβ | 239 |
Paraoxonase (PON1) Phenotype Is a Better Predictor of Vascular Disease Than Is
PON1
192
or
PON1
55
| 239 |
Human Paraoxonase-3 Is an HDL-Associated Enzyme With Biological Activity Similar to Paraoxonase-1 Protein but Is Not Regulated by Oxidized Lipids | 239 |
Involvement of RhoA/Rho Kinase Signaling in VEGF-Induced Endothelial Cell Migration and Angiogenesis In Vitro | 238 |
Effect of Immunization With Homologous LDL and Oxidized LDL on Early Atherosclerosis in Hypercholesterolemic Rabbits | 238 |
Expression of ICAM-1 and VCAM-1 and Monocyte Adherence in Arteries Exposed to Altered Shear Stress | 236 |
High-Density Lipoprotein Subpopulation Profile and Coronary Heart Disease Prevalence in Male Participants of the Framingham Offspring Study | 236 |
Nuclear Magnetic Resonance Spectroscopy of Lipoproteins and Risk of Coronary Heart Disease in the Cardiovascular Health Study | 235 |
Vaccine-Induced Antibodies Inhibit CETP Activity In Vivo and Reduce Aortic Lesions in a Rabbit Model of Atherosclerosis | 235 |
Hemodynamic Shear Stresses in Mouse Aortas | 233 |
Human Serum Paraoxonase/Arylesterase’s Retained Hydrophobic
N
-Terminal Leader Sequence Associates With HDLs by Binding Phospholipids | 233 |
Mercury, Fish Oils, and Risk of Acute Coronary Events and Cardiovascular Disease, Coronary Heart Disease, and All-Cause Mortality in Men in Eastern Finland | 232 |
Vastatins Inhibit Tissue Factor in Cultured Human Macrophages | 231 |
Promoter Polymorphisms of Human Paraoxonase
PON1
Gene and Serum Paraoxonase Activities and Concentrations | 230 |
Formation and Metabolism of Prebeta-Migrating, Lipid-Poor Apolipoprotein A-I | 229 |
Fractalkine in Vascular Biology | 229 |
Troglitazone Inhibits Atherosclerosis in Apolipoprotein E–Knockout Mice | 229 |
Differential Effects of Doxycycline, a Broad-Spectrum Matrix Metalloproteinase Inhibitor, on Angiotensin II–Induced Atherosclerosis and Abdominal Aortic Aneurysms | 228 |
Influence of Oscillatory and Unidirectional Flow Environments on the Expression of Endothelin and Nitric Oxide Synthase in Cultured Endothelial Cells | 228 |
Peroxisome Proliferator-Activated Receptor γ Ligands Increase Release of Nitric Oxide From Endothelial Cells | 227 |
Risk Factors for Abdominal Aortic Aneurysms in Older Adults Enrolled in the Cardiovascular Health Study | 227 |
Elevated Serum C-Reactive Protein Levels and Early Arterial Changes in Healthy Children | 226 |
The Failure of Torcetrapib | 225 |
Novel Conformation-Specific Antibodies Against Matrix γ-Carboxyglutamic Acid (Gla) Protein | 225 |
Diet and Murine Atherosclerosis | 224 |
Osteoprotegerin Inactivation Accelerates Advanced Atherosclerotic Lesion Progression and Calcification in Older ApoE
−/−
Mice | 224 |
Estrogen and Angiogenesis | 223 |
Oxysterols | 223 |
Unraveling the Reactions of Nitric Oxide, Nitrite, and Hemoglobin in Physiology and Therapeutics | 222 |
Thrombin-Induced Increase in Endothelial Permeability Is Associated With Changes in Cell-to-Cell Junction Organization | 222 |
Fibronectin | 221 |
Epidermal Growth Factor Receptor Transactivation by Angiotensin II Requires Reactive Oxygen Species in Vascular Smooth Muscle Cells | 221 |
Matrix Metalloproteinase-2 and −9 Differentially Regulate Smooth Muscle Cell Migration and Cell-Mediated Collagen Organization | 220 |
c-Src Induces Phosphorylation and Translocation of p47phox | 220 |
Human CRP Gene Polymorphism Influences CRP Levels | 220 |
Nitric Oxide Induces the Synthesis of Vascular Endothelial Growth Factor by Rat Vascular Smooth Muscle Cells | 219 |
Leukocytosis and Ischemic Vascular Disease Morbidity and Mortality | 217 |
Value of High-Density Lipoprotein (HDL) Subpopulations in Predicting Recurrent Cardiovascular Events in the Veterans Affairs HDL Intervention Trial | 217 |
Central Roles of α
5
β
1
Integrin and Fibronectin in Vascular Development in Mouse Embryos and Embryoid Bodies | 217 |
Potential Role of Endotoxin as a Proinflammatory Mediator of Atherosclerosis | 216 |
Production of the Long Pentraxin PTX3 in Advanced Atherosclerotic Plaques | 216 |
Pathogenesis of Calcific Aortic Valve Disease | 215 |
Intracellular Cholesterol Transport | 214 |
Unique Morphology and Focal Adhesion Development of Valvular Endothelial Cells in Static and Fluid Flow Environments | 214 |
Detection of Superoxide in Vascular Tissue | 213 |
Differential Activation of Mitogenic Signaling Pathways in Aortic Smooth Muscle Cells Deficient in Superoxide Dismutase Isoforms | 213 |
Coronary Artery Superoxide Production and Nox Isoform Expression in Human Coronary Artery Disease | 213 |
Interleukin-1β in Coronary Arteries of Patients With Ischemic Heart Disease | 212 |
Advanced Atherosclerotic Lesions in the Innominate Artery of the ApoE Knockout Mouse | 212 |
Role of Endothelial Nitric Oxide Synthase in Endothelial Cell Migration | 211 |
Influence of Interferon-γ on the Extent and Phenotype of Diet-Induced Atherosclerosis in the LDLR-Deficient Mouse | 211 |
Complement and Atherogenesis | 210 |
The Diagnostic Accuracy of Ex Vivo MRI for Human Atherosclerotic Plaque Characterization | 210 |
Association Between Serum Uric Acid, Metabolic Syndrome, and Carotid Atherosclerosis in Japanese Individuals | 209 |
Energy Restriction and Weight Loss on Very-Low-Fat Diets Reduce C-Reactive Protein Concentrations in Obese, Healthy Women | 209 |
Upregulation of Superoxide Dismutase and Nitric Oxide Synthase Mediates the Apoptosis-Suppressive Effects of Shear Stress on Endothelial Cells | 209 |
Ccr5 But Not Ccr1 Deficiency Reduces Development of Diet-Induced Atherosclerosis in Mice | 209 |
Genetic Cholesteryl Ester Transfer Protein Deficiency Is Extremely Frequent in the Omagari Area of Japan | 209 |
Angiopoietin-Like Protein3 Regulates Plasma HDL Cholesterol Through Suppression of Endothelial Lipase | 209 |
Impact of Body Mass Index on Coronary Heart Disease Risk Factors in Men and Women | 208 |
Oxidative Stress in Human Abdominal Aortic Aneurysms | 208 |
Direct Detection and Quantification of Transition Metal Ions in Human Atherosclerotic Plaques: Evidence for the Presence of Elevated Levels of Iron and Copper | 207 |
Apolipoprotein A-I Mimetic Peptides | 207 |
Effect of Rosiglitazone on Common Carotid Intima-Media Thickness Progression in Coronary Artery Disease Patients Without Diabetes Mellitus | 206 |
Increased Superoxide Production in Coronary Arteries in Hyperhomocysteinemia | 205 |
Shear Stress Induces Endothelial Differentiation From a Murine Embryonic Mesenchymal Progenitor Cell Line | 204 |
Risk Factors Related to Carotid Intima-Media Thickness and Plaque in Children With Familial Hypercholesterolemia and Control Subjects | 204 |
Hepatic Steatosis: A Mediator of the Metabolic Syndrome. Lessons From Animal Models | 203 |
Role of Matrix Metalloproteinases in Blood Flow–Induced Arterial Enlargement | 203 |
Bisphosphonates Alendronate and Ibandronate Inhibit Artery Calcification at Doses Comparable to Those That Inhibit Bone Resorption | 203 |
The Role of Interleukin 12 in the Development of Atherosclerosis in ApoE-Deficient Mice | 203 |
Differential Accumulation of Proteoglycans and Hyaluronan in Culprit Lesions | 203 |
Increased Expression of the DNA-Binding Cytokine HMGB1 in Human Atherosclerotic Lesions | 203 |
von Willebrand Factor, C-Reactive Protein, and 5-Year Mortality in Diabetic and Nondiabetic Subjects | 203 |
Transforming Growth Factor-βs and Vascular Disorders | 202 |
Selective Retention of VLDL, IDL, and LDL in the Arterial Intima of Genetically Hyperlipidemic Rabbits In Vivo | 202 |
Receptor for Advanced Glycation End Products Mediates Inflammation and Enhanced Expression of Tissue Factor in Vasculature of Diabetic Apolipoprotein E–Null Mice | 202 |
Progression of Atheroma | 201 |
Immunization of LDL Receptor–Deficient Mice With Homologous Malondialdehyde-Modified and Native LDL Reduces Progression of Atherosclerosis by Mechanisms Other Than Induction of High Titers of Antibodi | 201 |
Measuring Plasma Fibrinogen to Predict Stroke and Myocardial Infarction | 200 |
Regulation of Blood Coagulation by the Protein C Anticoagulant Pathway | 200 |
Expression of CCR2 by Endothelial Cells | 200 |
Toll-Like Receptor 4–Dependent and –Independent Cytokine Secretion Induced by Minimally Oxidized Low-Density Lipoprotein in Macrophages | 200 |
Vascular Endothelial Growth Factor/Vascular Permeability Factor Produces Nitric Oxide–Dependent Hypotension | 200 |
Regulation and Mechanisms of ATP-Binding Cassette Transporter A1-Mediated Cellular Cholesterol Efflux | 199 |
Efflux and Atherosclerosis | 199 |
Systemic Inflammatory Parameters in Patients With Atherosclerosis of the Coronary and Peripheral Arteries | 199 |
Effects of Coronary Heart Disease Risk Factors on Atherosclerosis of Selected Regions of the Aorta and Right Coronary Artery | 199 |
Evidence of Hypoxic Areas Within the Arterial Wall In Vivo | 198 |
Elevated Fasting Total Plasma Homocysteine Levels and Cardiovascular Disease Outcomes in Maintenance Dialysis Patients | 198 |
Cyclooxygenase-2 Is Widely Expressed in Atherosclerotic Lesions Affecting Native and Transplanted Human Coronary Arteries and Colocalizes With Inducible Nitric Oxide Synthase and Nitrotyrosine Particu | 198 |
LDL Cholesterol as a Strong Predictor of Coronary Heart Disease in Diabetic Individuals With Insulin Resistance and Low LDL | 197 |
Nuclear Receptors Nur77, Nurr1, and NOR-1 Expressed in Atherosclerotic Lesion Macrophages Reduce Lipid Loading and Inflammatory Responses | 197 |
Transforming Growth Factor β and Atherosclerosis: So Far, So Good for the Protective Cytokine Hypothesis | 196 |
β-Glycerophosphate Accelerates Calcification in Cultured Bovine Vascular Smooth Muscle Cells | 196 |
Inhibition of Atherosclerosis in ApoE-Null Mice by Immunization with ApoB-100 Peptide Sequences | 196 |
Genetic Contribution of the Endothelial Constitutive Nitric Oxide Synthase Gene to Plasma Nitric Oxide Levels | 195 |
Neutrophil Extracellular Traps | 195 |
Evaluation of Endothelial Shear Stress and 3D Geometry as Factors Determining the Development of Atherosclerosis and Remodeling in Human Coronary Arteries in Vivo | 195 |
ACE
Gene Polymorphism in Cardiovascular Disease | 194 |
Activation of PPARβ/δ Induces Endothelial Cell Proliferation and Angiogenesis | 194 |
Regulation of Endothelial Cell Survival and Apoptosis During Angiogenesis | 193 |
Elevated Factor VIII Levels and the Risk of Thrombosis | 193 |
Regulation of Vascular Smooth Muscle Cell Migration and Proliferation In Vitro and in Injured Rat Arteries by a Synthetic Matrix Metalloproteinase Inhibitor | 193 |
Antidiabetic PPARγ-Activator Rosiglitazone Reduces MMP-9 Serum Levels in Type 2 Diabetic Patients With Coronary Artery Disease | 193 |
Lysophosphatidic Acid Induces Thrombogenic Activity Through Phosphatidylserine Exposure and Procoagulant Microvesicle Generation in Human Erythrocytes | 193 |
Circulating Vascular Cell Adhesion Molecule-1 Correlates With the Extent of Human Atherosclerosis in Contrast to Circulating Intercellular Adhesion Molecule-1, E-Selectin, P-Selectin, and Thrombomodul | 193 |
The Transcription Factor NF-κB and the Regulation of Vascular Cell Function | 192 |
Homocyst(e)ine and Risk of Cardiovascular Disease in the Multiple Risk Factor Intervention Trial | 192 |
Telomere Shortening in Human Coronary Artery Diseases | 192 |
Association of the Toll-Like Receptor 4 Gene Asp299Gly Polymorphism With Acute Coronary Events | 192 |
Circle of Willis Atherosclerosis Is a Risk Factor for Sporadic Alzheimer’s Disease | 192 |
Granulocyte Colony-Stimulating Factor Mobilizes Functional Endothelial Progenitor Cells in Patients With Coronary Artery Disease | 192 |
Effects of Cholesteryl Ester Transfer Protein Inhibition on High-Density Lipoprotein Subspecies, Apolipoprotein A-I Metabolism, and Fecal Sterol Excretion | 192 |
Tissue Factor Encryption | 191 |
Elevated Circulating Levels of Inflammatory Cytokines in Patients With Abdominal Aortic Aneurysm | 191 |
Human Endothelial Progenitor Cells Tolerate Oxidative Stress Due to Intrinsically High Expression of Manganese Superoxide Dismutase | 191 |
Overproduction of VLDL
1
Driven by Hyperglycemia Is a Dominant Feature of Diabetic Dyslipidemia | 191 |
Matrix Metalloproteinase 2 Activation of Transforming Growth Factor-β1 (TGF-β1) and TGF-β1–Type II Receptor Signaling Within the Aged Arterial Wall | 191 |
Influence of Cardiovascular Risk Factors on Endothelial Progenitor Cells | 190 |
Missense Mutations in the PCSK9 Gene Are Associated With Hypocholesterolemia and Possibly Increased Response to Statin Therapy | 190 |
Effect of Human Recombinant Interleukin-6 and Interleukin-8 on Monocyte Procoagulant Activity | 190 |
Heart Rate Variability and Progression of Coronary Atherosclerosis | 190 |
Influence of the HDL Receptor SR-BI on Lipoprotein Metabolism and Atherosclerosis | 189 |
Physical Inactivity Increases Oxidative Stress, Endothelial Dysfunction, and Atherosclerosis | 189 |
Identification of Unique Lipoprotein Subclasses for Visceral Obesity by Component Analysis of Cholesterol Profile in High-Performance Liquid Chromatography | 189 |
The Effects of Folic Acid Supplementation on Plasma Total Homocysteine Are Modulated by Multivitamin Use and Methylenetetrahydrofolate Reductase Genotypes | 188 |
Effects of Reducing Dietary Saturated Fatty Acids on Plasma Lipids and Lipoproteins in Healthy Subjects | 188 |
T Cells in Atherogenesis | 187 |
Manipulating Angiogenesis | 186 |
Chemokines | 186 |
Serum Paraoxonase After Myocardial Infarction | 186 |
Soy Protein Versus Soy Phytoestrogens in the Prevention of Diet-Induced Coronary Artery Atherosclerosis of Male Cynomolgus Monkeys | 186 |
Matrix Metalloproteinase-2 Production and Its Binding to the Matrix Are Increased in Abdominal Aortic Aneurysms | 186 |
Relation of Plaque Lipid Composition and Morphology to the Stability of Human Aortic Plaques | 185 |
Functional Properties of Human Vascular Endothelial Cadherin (7B4/Cadherin-5), an Endothelium-Specific Cadherin | 185 |
Biomechanical Determinants of Abdominal Aortic Aneurysm Rupture | 184 |
Statins and Blood Coagulation | 184 |
High-Density Lipoprotein Stimulates Endothelial Cell Migration and Survival Through Sphingosine 1-Phosphate and Its Receptors | 184 |
Hemostatic Factors as Predictors of Ischemic Heart Disease and Stroke in the Edinburgh Artery Study | 184 |
Vascular Endothelial Growth Factor–Expressing Mesenchymal Stem Cell Transplantation for the Treatment of Acute Myocardial Infarction | 184 |
HDL Apolipoproteins and ABCA1 | 183 |
Plaque Rupture in Humans and Mice | 183 |
Role of Serum Amyloid A During Metabolism of Acute-Phase HDL by Macrophages | 183 |
Plasma Concentration of Asymmetric Dimethylarginine, an Endogenous Inhibitor of Nitric Oxide Synthase, Is Elevated in Monkeys With Hyperhomocyst(e)inemia or Hypercholesterolemia | 183 |
Circulating Cell Adhesion Molecules Are Correlated With Ultrasound-Based Assessment of Carotid Atherosclerosis | 183 |
The Adipocyte and Hemostatic Balance in Obesity | 182 |
Are Retinal Arteriolar Abnormalities Related to Atherosclerosis? | 182 |
Endothelial Protection by High-Density Lipoproteins | 181 |
Cyclophilin A Is a Proinflammatory Cytokine that Activates Endothelial Cells | 181 |
Hyperleptinemia as a Component of a Metabolic Syndrome of Cardiovascular Risk | 181 |
ApoE Polymorphism and Fish Oil Supplementation in Subjects With an Atherogenic Lipoprotein Phenotype | 181 |
Sphingolipids in Atherosclerosis and Vascular Biology | 180 |
Potassium Channel Function in Vascular Disease | 180 |
PI3K-Akt Pathway Suppresses Coagulation and Inflammation in Endotoxemic Mice | 180 |
LDL Immunization Induces T-Cell–Dependent Antibody Formation and Protection Against Atherosclerosis | 180 |
Homocysteine as a Risk Factor for Vascular Disease | 180 |
Oxidized LDL Binds to CD36 on Human Monocyte-Derived Macrophages and Transfected Cell Lines | 180 |
Implications of Early Structural-Functional Changes in the Endothelium for Vascular Disease | 179 |
Stable Compounds of Cigarette Smoke Induce Endothelial Superoxide Anion Production via NADPH Oxidase Activation | 179 |
Relation of High TG–Low HDL Cholesterol and LDL Cholesterol to the Incidence of Ischemic Heart Disease | 179 |
Establishment of a High Sensitivity Plasma Assay for Human Pentraxin3 as a Marker for Unstable Angina Pectoris | 179 |
Contribution of Gene Sequence Variations of the Hepatic Cytochrome P450 3A4 Enzyme to Variability in Individual Responsiveness to Clopidogrel | 179 |
Anoïkis in the Cardiovascular System | 178 |
Macrophage Scavenger Receptor Class A | 178 |
Bilirubin From Heme Oxygenase-1 Attenuates Vascular Endothelial Activation and Dysfunction | 178 |
Expression of Interleukin-10 in Advanced Human Atherosclerotic Plaques | 178 |
Histamine Induces Tyrosine Phosphorylation of Endothelial Cell-to-Cell Adherens Junctions | 177 |
Angiotensin II Induces Endothelial Xanthine Oxidase Activation | 177 |
Smooth Muscle Cells in Atherosclerosis Originate From the Local Vessel Wall and Not Circulating Progenitor Cells in ApoE Knockout Mice | 177 |
Cholesteryl Ester Transfer Protein Decreases High-Density Lipoprotein and Severely Aggravates Atherosclerosis in
APOE*3-Leiden
Mice | 177 |
Relative Contribution of Insulin and Its Precursors to Fibrinogen and PAI-1 in a Large Population With Different States of Glucose Tolerance | 177 |
Increased Platelet Aggregability Associated With Platelet
GPIIIa Pl
A2
Polymorphism
| 177 |
Shear Stress Activates p60src-Ras-MAPK Signaling Pathways in Vascular Endothelial Cells | 176 |
HMG CoA Reductase Inhibitors Reduce Plasminogen Activator Inhibitor-1 Expression by Human Vascular Smooth Muscle and Endothelial Cells | 175 |
Macrophage Liver X Receptor Is Required for Antiatherogenic Activity of LXR Agonists | 175 |
In the Elderly, Interleukin-6 Plasma Levels and the −174G>C Polymorphism Are Associated With the Development of Cardiovascular Disease | 175 |
A General Strategy for Isolation of Endothelial Cells From Murine Tissues | 175 |
LXR-Induced Redistribution of ABCG1 to Plasma Membrane in Macrophages Enhances Cholesterol Mass Efflux to HDL | 174 |
Circumferential Stress and Matrix Metalloproteinase 1 in Human Coronary Atherosclerosis | 174 |
Deficiency of Inflammatory Cell Adhesion Molecules Protects Against Atherosclerosis in Mice | 174 |
Elevated Fluid Shear Stress Enhances Postocclusive Collateral Artery Growth and Gene Expression in the Pig Hind Limb | 174 |
Inhibition of Thromboxane Biosynthesis and Platelet Function by Simvastatin in Type IIa Hypercholesterolemia | 173 |
Coadministration of Angiopoietin-1 and Vascular Endothelial Growth Factor Enhances Collateral Vascularization | 173 |
Integrin–Matrix Interactions in the Cerebral Microvasculature | 172 |
Statins Reduce Interleukin-6–Induced C-Reactive Protein in Human Hepatocytes | 172 |
Impact of Mouse Strain Differences in Innate Hindlimb Collateral Vasculature | 172 |
Relation of Glycohemoglobin and Adiposity to Atherosclerosis in Youth | 171 |
Leptin Promotes Vascular Remodeling and Neointimal Growth in Mice | 171 |
Reduced Macrophage Apoptosis Is Associated With Accelerated Atherosclerosis in Low-Density Lipoprotein Receptor-Null Mice | 171 |
Calcification of Human Vascular Cells In Vitro Is Correlated With High Levels of Matrix Gla Protein and Low Levels of Osteopontin Expression | 171 |
Genistein, the Dietary-Derived Angiogenesis Inhibitor, Prevents LDL Oxidation and Protects Endothelial Cells From Damage by Atherogenic LDL | 171 |
Association of C-Reactive Protein With Carotid Atherosclerosis in Men and Women: The Framingham Heart Study | 171 |
Lipoprotein-Associated Phospholipase A
2
, Platelet-Activating Factor Acetylhydrolase, Is Expressed by Macrophages in Human and Rabbit Atherosclerotic Lesions | 171 |
Statins Reduce Inflammation in Atheroma of Nonhuman Primates Independent of Effects on Serum Cholesterol | 170 |
Interaction of Oxidative Stress and Inflammatory Response in Coronary Plaque Instability | 170 |
Lesional Overexpression of Matrix Metalloproteinase-9 Promotes Intraplaque Hemorrhage in Advanced Lesions But Not at Earlier Stages of Atherogenesis | 169 |
Dose-Dependent Regulation of NAD(P)H Oxidase Expression by Angiotensin II in Human Endothelial Cells | 169 |
The Metabolic Syndrome, LDL Particle Size, and Atherosclerosis | 168 |
Shear Stress Gradients Remodel Endothelial Monolayers in Vitro via a Cell Proliferation-Migration-Loss Cycle | 168 |
Characteristics of Intact and Ruptured Atherosclerotic Plaques in Brachiocephalic Arteries of Apolipoprotein E Knockout Mice | 168 |
Decreased Reverse Cholesterol Transport from Tangier Disease Fibroblasts | 168 |
Soluble Vascular Cell Adhesion Molecule-1 as a Biohumoral Correlate of Atherosclerosis | 168 |
Vascular Endothelial Growth Factor Activates PI3K/Akt/Forkhead Signaling in Endothelial Cells | 168 |
Single and Combined Prothrombotic Factors in Patients With Idiopathic Venous Thromboembolism | 168 |
Lipid Inflammatory Mediators in Diabetic Vascular Disease | 167 |
Rapid Analysis of Angiogenesis Drugs in a Live Fluorescent Zebrafish Assay | 167 |
Activation of Matrix-Degrading Metalloproteinases by Mast Cell Proteases in Atherosclerotic Plaques | 167 |
Relation of Intima-Media Thickness to Atherosclerotic Plaques in Carotid Arteries | 167 |
Relation Between Insulin Resistance, Hyperinsulinemia, Postheparin Plasma Lipoprotein Lipase Activity, and Postprandial Lipemia | 167 |
AMP-Activated Protein Kinase Is Involved in Endothelial NO Synthase Activation in Response to Shear Stress | 167 |
CLA-1 Is an 85-kD Plasma Membrane Glycoprotein That Acts as a High-Affinity Receptor for Both Native (HDL, LDL, and VLDL) and Modified (OxLDL and AcLDL) Lipoproteins | 167 |
Reactive Oxygen Species Regulate Heat-Shock Protein 70 via the JAK/STAT Pathway | 166 |
Scavenger Receptor Class B Type I–Mediated Protection Against Atherosclerosis in LDL Receptor–Negative Mice Involves Its Expression in Bone Marrow–Derived Cells | 166 |
Lipoprotein(a) | 165 |
Nitric Oxide Synthases and Cardiac Muscle | 165 |
Genetic Ablation of Caveolin-1 Confers Protection Against Atherosclerosis | 165 |
Hyperglycemia Reduces Survival and Impairs Function of Circulating Blood-Derived Progenitor Cells | 165 |
Overexpression of 15-Lipoxygenase in Vascular Endothelium Accelerates Early Atherosclerosis in LDL Receptor–Deficient Mice | 165 |
Transfer of Endothelial Progenitor and Bone Marrow Cells Influences Atherosclerotic Plaque Size and Composition in Apolipoprotein E Knockout Mice | 165 |
Role of Leukotriene B
4
Receptors in the Development of Atherosclerosis: Potential Mechanisms | 165 |
Signaling of the Tissue Factor Coagulation Pathway in Angiogenesis and Cancer | 164 |
Isoflavones Reduce Arterial Stiffness | 164 |
Phagocytosis and Macrophage Activation Associated With Hemorrhagic Microvessels in Human Atherosclerosis | 164 |
The Thromboxane Receptor Antagonist S18886 but Not Aspirin Inhibits Atherogenesis in Apo E–Deficient Mice | 164 |
Proatherogenic Role of Elevated CE Transfer From HDL to VLDL
1
and Dense LDL in Type 2 Diabetes | 164 |
The Lamina Adventitia Is the Major Site of Immune Cell Accumulation in Standard Chow-Fed Apolipoprotein E–Deficient Mice | 164 |
Serum Total IGF-I, Free IGF-I, and IGFBP-1 Levels in an Elderly Population | 164 |
Effect of Oral Postmenopausal Hormone Replacement on Progression of Atherosclerosis | 163 |
Angiotensinogen Gene Polymorphism, Plasma Angiotensinogen, and Risk of Hypertension and Ischemic Heart Disease | 163 |
Action of Atorvastatin in Combined Hyperlipidemia | 163 |
Effect of the Novel Antiplatelet Agent Cilostazol on Plasma Lipoproteins in Patients With Intermittent Claudication | 163 |
Role of Group II Secretory Phospholipase A
2
in Atherosclerosis | 163 |
Atherosclerosis in Patients With Autoimmune Disorders | 162 |
Compared With Dietary Monounsaturated and Saturated Fat, Polyunsaturated Fat Protects African Green Monkeys From Coronary Artery Atherosclerosis | 162 |
Nonfasting Apolipoprotein B and Triglyceride Levels as a Useful Predictor of Coronary Heart Disease Risk in Middle-Aged UK Men | 162 |
Association Between Elevated Liver Enzymes and C-Reactive Protein | 162 |
Only the Two End Helixes of Eight Tandem Amphipathic Helical Domains of Human Apo A-I Have Significant Lipid Affinity | 162 |
Metabolic Syndrome Scientific Statement by the American Heart Association and the National Heart, Lung, and Blood Institute | 161 |
Elevated Interleukin-18 Levels Are Associated With the Metabolic Syndrome Independent of Obesity and Insulin Resistance | 161 |
Interactions Between Dietary Fat, Fish, and Fish Oils and Their Effects on Platelet Function in Men at Risk of Cardiovascular Disease | 161 |
Macrophage ABCG1 Deletion Disrupts Lipid Homeostasis in Alveolar Macrophages and Moderately Influences Atherosclerotic Lesion Development in LDL Receptor-Deficient Mice | 161 |
Triglyceride:High-Density Lipoprotein Cholesterol Effects in Healthy Subjects Administered a Peroxisome Proliferator Activated Receptor δ Agonist | 161 |
Dietary Factors That Promote or Retard Inflammation | 160 |
Development of the Lipid-Rich Core in Human Atherosclerosis | 160 |
Effect of Simvastatin Therapy on Paraoxonase Activity and Related Lipoproteins in Familial Hypercholesterolemic Patients | 160 |
Genes, Environment, and Cardiovascular Disease | 159 |
Noncholesterol Sterols and Cholesterol Lowering by Long-Term Simvastatin Treatment in Coronary Patients | 159 |
Warfarin-Induced Artery Calcification Is Accelerated by Growth and Vitamin D | 158 |
Smooth Muscle Cell Origin and Its Relation to Heterogeneity in Development and Disease | 158 |
Insulin-Mediated Stimulation of Protein Kinase Akt | 158 |
Peroxynitrite Causes Endoplasmic Reticulum Stress and Apoptosis in Human Vascular Endothelium | 158 |
Molecular Characterization and Localization of the NAD(P)H Oxidase Components gp91-
phox
and p22-
phox
in Endothelial Cells | 158 |
Fibrinolytic Activation Markers Predict Myocardial Infarction in the Elderly | 158 |
Increased Atherosclerosis in ApoE and LDL Receptor Gene Knock-Out Mice as a Result of Human Cholesteryl Ester Transfer Protein Transgene Expression | 158 |
Flow-Induced Vascular Remodeling in the Mouse | 157 |
Temporal Gradient in Shear But Not Steady Shear Stress Induces PDGF-A and MCP-1 Expression in Endothelial Cells | 157 |
Lipoprotein-Associated Phospholipase A
2
Predicts Future Cardiovascular Events in Patients With Coronary Heart Disease Independently of Traditional Risk Factors, Mar | 157 |
Heme Oxygenase and Atherosclerosis | 156 |
Monounsaturated Versus Polyunsaturated Dietary Fat and Serum Lipids | 156 |
Impaired Responsiveness to NO in Newly Diagnosed Patients With Rheumatoid Arthritis | 156 |
Asymmetrical Dimethylarginine in Idiopathic Pulmonary Arterial Hypertension | 156 |
Arterial Mechanical Changes in Children With Familial Hypercholesterolemia | 156 |
At Least 2 Distinct Pathways Generating Reactive Oxygen Species Mediate Vascular Cell Adhesion Molecule-1 Induction by Advanced Glycation End Products | 156 |
Expression of Extracellular SOD and iNOS in Macrophages and Smooth Muscle Cells in Human and Rabbit Atherosclerotic Lesions | 156 |
Smooth Muscle Cell Heterogeneity | 155 |
Patients With Early-Onset Peripheral Vascular Disease Have Increased Levels of Autoantibodies Against Oxidized LDL | 155 |
Increased Endothelial Tetrahydrobiopterin Synthesis by Targeted Transgenic GTP-Cyclohydrolase I Overexpression Reduces Endothelial Dysfunction and Atherosclerosis in ApoE-Knockout Mice | 155 |
In Vivo Characterization and Quantification of Atherosclerotic Carotid Plaque Components With Multidetector Computed Tomography and Histopathological Correlation | 155 |
Heparin-Binding Domains in Vascular Biology | 154 |
Thrombotic Risk in Hereditary Antithrombin III, Protein C, or Protein S Deficiency | 154 |
Apolipoprotein B100 Metabolism in Autosomal-Dominant Hypercholesterolemia Related to Mutations in
PCSK9 | 154 |
Plasma Total Homocysteine, B Vitamins, and Risk of Coronary Atherosclerosis | 154 |
Oxidized LDL Modulates Bax/Bcl-2 Through the Lectinlike Ox-LDL Receptor-1 in Vascular Smooth Muscle Cells | 154 |
Redox Status and Protein Binding of Plasma Homocysteine and Other Aminothiols in Patients With Early-Onset Peripheral Vascular Disease | 154 |
Supplementation With Low Doses of Vitamin E Protects LDL From Lipid Peroxidation in Men and Women | 154 |
Identification of Immune Responses Against Aldehyde-Modified Peptide Sequences in ApoB Associated With Cardiovascular Disease | 154 |
Intravascular Modalities for Detection of Vulnerable Plaque | 153 |
Apolipoprotein(a) Kringle IV Repeat Number Predicts Risk for Coronary Heart Disease | 153 |
Inherited Apolipoprotein A-V Deficiency in Severe Hypertriglyceridemia | 153 |
Heterogeneity at the
CETP
Gene Locus | 153 |
Association of C-Reactive Protein With Blood Pressure and Hypertension | 153 |
Homocysteine and Its Disulfide Derivatives | 153 |
Hopelessness and 4-Year Progression of Carotid Atherosclerosis | 152 |
Age and Sex Distribution of Subclinical Aortic Atherosclerosis | 152 |
Determinants of Bioactivity of Oxidized Phospholipids | 152 |
von Willebrand Factor | 151 |
Treatment With Statins After Induction of Focal Ischemia in Rats Reduces the Extent of Brain Damage | 151 |
Transcriptional Regulation of Tissue Factor Expression in Human Endothelial Cells | 150 |
Mitogen-Activated Protein Kinases Mediate Matrix Metalloproteinase-9 Expression in Vascular Smooth Muscle Cells | 150 |
Prospective Study of Fibrinolytic Factors and Incident Coronary Heart Disease | 150 |
Glucose-6-Phosphate Dehydrogenase Overexpression Decreases Endothelial Cell Oxidant Stress and Increases Bioavailable Nitric Oxide | 150 |
Niacin Decreases Removal of High-Density Lipoprotein Apolipoprotein A-I But Not Cholesterol Ester by Hep G2 Cells | 150 |
Nitric Oxide Production Is Reduced in Patients With Chronic Renal Failure | 150 |
High Glucose Induces Human Endothelial Cell Apoptosis Through a Phosphoinositide 3-Kinase–Regulated Cyclooxygenase-2 Pathway | 150 |
Severe Hypercholesterolemia in Four British Families With the D374Y Mutation in the PCSK9 Gene | 150 |
Shear Stress Increases ICAM-1 and Decreases VCAM-1 and E-selectin Expressions Induced by Tumor Necrosis Factor-α in Endothelial Cells | 150 |
Fast Food, Central Nervous System Insulin Resistance, and Obesity | 149 |
Role of Platelet P-Selectin and CD40 Ligand in the Induction of Monocytic Tissue Factor Expression | 149 |
Function of the Plasminogen/Plasmin and Matrix Metalloproteinase Systems After Vascular Injury in Mice With Targeted Inactivation of Fibrinolytic System Genes | 149 |
Oleic Acid Inhibits Endothelial Activation | 149 |
Association of Polymorphisms at the SR-BI Gene Locus With Plasma Lipid Levels and Body Mass Index in a White Population | 149 |
Platelet Inhibition by Insulin Is Absent in Type 2 Diabetes Mellitus | 148 |
Increased Serum Levels of Heat Shock Protein 70 Are Associated With Low Risk of Coronary Artery Disease | 148 |
Conditional Knockout of Macrophage PPARγIncreases Atherosclerosis in C57BL/6 and Low-Density Lipoprotein Receptor–Deficient Mice | 148 |
Acute Elevations of Plasma Asymmetric Dimethylarginine and Impaired Endothelial Function in Response to a High-Fat Meal in Patients With Type 2 Diabetes | 148 |
C-Reactive Protein, Cardiovascular Risk Factors, and Mortality in a Prospective Study in the Elderly | 147 |
Effect of MMP-2 Deficiency on Atherosclerotic Lesion Formation in ApoE-Deficient Mice | 147 |
Fas Is Expressed in Human Atherosclerotic Intima and Promotes Apoptosis of Cytokine-Primed Human Vascular Smooth Muscle Cells | 147 |
Resveratrol, a Polyphenolic Compound Found in Wine, Inhibits Tissue Factor Expression in Vascular Cells | 147 |
CXCL16/SR-PSOX Is an Interferon-γ–Regulated Chemokine and Scavenger Receptor Expressed in Atherosclerotic Lesions | 147 |
A Proinflammatory State Is Detectable in Obese Children and Is Accompanied by Functional and Morphological Vascular Changes | 147 |
Oxidative Stress and Vascular Disease | 146 |
Platelet-Leukocyte Cross Talk in Whole Blood | 146 |
Increased Immunolocalization of Paraoxonase, Clusterin, and Apolipoprotein A-I in the Human Artery Wall With the Progression of Atherosclerosis | 146 |
Distribution of ApoA-I–Containing HDL Subpopulations in Patients With Coronary Heart Disease | 146 |
Synergistic Effects of Fluid Shear Stress and Cyclic Circumferential Stretch on Vascular Endothelial Cell Morphology and Cytoskeleton | 146 |
Bicuspid Aortic Valve Associated With Aortic Dilatation | 146 |
Association of Serum Vitamin Levels, LDL Susceptibility to Oxidation, and Autoantibodies Against MDA-LDL With Carotid Atherosclerosis | 146 |
Weight Reduction With Very-Low-Caloric Diet and Endothelial Function in Overweight Adults: Role of Plasma Glucose | 146 |
Specific Phospholipid Oxidation Products Inhibit Ligand Activation of Toll-Like Receptors 4 and 2 | 146 |
Proteomic and Metabolomic Analyses of Atherosclerotic Vessels From Apolipoprotein E-Deficient Mice Reveal Alterations in Inflammation, Oxidative Stress, and Energy Metabolism | 146 |
New Links Between Inflammation and Thrombosis | 145 |
High-Density Lipoproteins Enhance Progenitor-Mediated Endothelium Repair in Mice | 145 |
Transcriptional Profiles of Valvular and Vascular Endothelial Cells Reveal Phenotypic Differences | 145 |
Rat Aortic MCP-1 and Its Receptor CCR2 Increase With Age and Alter Vascular Smooth Muscle Cell Function | 145 |
Prostaglandin F
2
-Like Compounds, F
2
-Isoprostanes, Are Present in Increased Amounts in Human Atherosclerotic Lesions | 145 |
Human Plasma Phospholipid Transfer Protein Increases the Antiatherogenic Potential of High Density Lipoproteins in Transgenic Mice | 145 |
Smooth Muscle Cells Contribute the Majority of Foam Cells in ApoE (Apolipoprotein E)-Deficient Mouse Atherosclerosis | 145 |
Simvastatin Inhibits Leukocyte–Endothelial Cell Interactions and Protects Against Inflammatory Processes in Normocholesterolemic Rats | 144 |
Oxidized Omega-3 Fatty Acids Inhibit NF-κB Activation Via a PPARα-Dependent Pathway | 144 |
Systematic Review on the Risk and Benefit of Different Cholesterol-Lowering Interventions | 144 |
LDL Containing Apolipoprotein CIII Is an Independent Risk Factor for Coronary Events in Diabetic Patients | 144 |
Role of Nuclear Factor-κB Activation in Metalloproteinase-1, -3, and -9 Secretion by Human Macrophages In Vitro and Rabbit Foam Cells Produced In Vivo | 144 |
Common Carotid Intima-Media Thickness Predicts Occurrence of Carotid Atherosclerotic Plaques | 144 |
Differential Activation of Mitogen-Activated Protein Kinases in Smooth Muscle Cells by Angiotensin II | 144 |
Elevated Circulating Levels of Monocyte Chemoattractant Protein-1 in Patients With Restenosis After Coronary Angioplasty | 144 |
Characterization and Comparison of the Mode of Cell Death, Apoptosis Versus Necrosis, Induced by 7β-Hydroxycholesterol and 7-Ketocholesterol in the Cells of the Vascular Wall | 144 |
Thrombin Activatable Fibrinolysis Inhibitor and an Antifibrinolytic Pathway | 143 |
Oxidative Enzymopathies and Vascular Disease | 143 |
Tetrahydrobiopterin and Cardiovascular Disease | 143 |
Apoptosis in the Atherosclerotic Plaque | 143 |
Specific Impairment of Human Platelet P2Y
AC
ADP Receptor–Mediated Signaling by the Antiplatelet Drug Clopidogrel | 143 |
Peroxidase Properties of Extracellular Superoxide Dismutase | 143 |
Correlation of a Common Mutation in the Methylenetetrahydrofolate Reductase Gene With Plasma Homocysteine in Patients With Premature Coronary Artery Disease | 143 |
PAF-Degrading Acetylhydrolase Is Preferentially Associated With Dense LDL and VHDL-1 in Human Plasma | 143 |
Deficiency of Glutathione Peroxidase-1 Accelerates the Progression of Atherosclerosis in Apolipoprotein E-Deficient Mice | 143 |
Role of Vascular Smooth Muscle Cell Phenotypic Switching and Calcification in Aortic Aneurysm Formation | 143 |
Oligoclonal T Cell Expansions in Atherosclerotic Lesions of Apolipoprotein E–Deficient Mice | 142 |
Increased Autoantibody Titers Against Epitopes of Oxidized LDL in LDL Receptor–Deficient Mice With Increased Atherosclerosis | 142 |
Ligand Specificity of LOX-1, a Novel Endothelial Receptor for Oxidized Low Density Lipoprotein | 142 |
Oxidized LDL–Induced NF-κB Activation and Subsequent Expression of Proinflammatory Genes Are Defective in Monocyte-Derived Macrophages From CD36-Deficient Patients | 142 |
Monocyte Chemoattractant Protein-1 Induces Proliferation and Interleukin-6 Production in Human Smooth Muscle Cells by Differential Activation of Nuclear Factor-κB and Activator Protein-1 | 142 |
Aortic Valve Calcification | 142 |
Nitric Oxide and Endoplasmic Reticulum Stress | 141 |
Interleukin-1 Receptor Antagonist Expression in Human Endothelial Cells and Atherosclerosis | 141 |
Thrombin and Phenotypic Modulation of the Endothelium | 141 |
NAD(P)H Oxidase Mediates Angiotensin II–Induced Vascular Macrophage Infiltration and Medial Hypertrophy | 141 |
Influence of Biochemical Alterations on Arterial Stiffness in Patients With End-stage Renal Disease | 141 |
Antibodies Against Cardiolipin and Oxidatively Modified LDL in 50-Year-Old Men Predict Myocardial Infarction | 141 |
Adipocyte Fatty Acid–Binding Protein, aP2, Alters Late Atherosclerotic Lesion Formation in Severe Hypercholesterolemia | 141 |
Effect of Peroxisome Proliferator–Activated Receptor-α and -γ Activators on Vascular Remodeling in Endothelin-Dependent Hypertension | 141 |
Egr-1 is Activated in Endothelial Cells Exposed to Fluid Shear Stress and Interacts With a Novel Shear-Stress-Response Element in the PDGF A-Chain Promoter | 141 |
IL-8 Plasma Concentrations and the Risk of Future Coronary Artery Disease in Apparently Healthy Men and Women | 141 |
Hepatic Lipase, Lipoprotein Metabolism, and Atherogenesis | 140 |
Non-Exercise Activity Thermogenesis | 140 |
Cytosolic Lipid Droplets Increase in Size by Microtubule-Dependent Complex Formation | 140 |
7E3 Monoclonal Antibody Directed Against the Platelet Glycoprotein IIb/IIIa Cross-reacts With the Leukocyte Integrin Mac-1 and Blocks Adhesion to Fibrinogen and ICAM-1 | 140 |
ADP Receptor P2Y
12
Is Expressed in Vascular Smooth Muscle Cells and Stimulates Contraction in Human Blood Vessels | 140 |
Impaired Development of Atherosclerosis in Hyperlipidemic
Ldlr
−/−
and
ApoE
−/−
Mice Transpl | 140 |
Thiazolidinediones and Blood Lipids in Type 2 Diabetes | 139 |
HDL and ApoA Prevent Cell Death of Endothelial Cells Induced by Oxidized LDL | 139 |
Adipophilin Enhances Lipid Accumulation and Prevents Lipid Efflux From THP-1 Macrophages | 139 |
Shear Stress Inhibits H
2
O
2
-Induced Apoptosis of Human Endothelial Cells by Modulation of the Glutathione Redox Cycle and Nitri | 139 |
Stromelysin-1 and Interleukin-6 Gene Promoter Polymorphisms Are Determinants of Asymptomatic Carotid Artery Atherosclerosis | 139 |
Asymmetric Dimethylarginine Produces Vascular Lesions in Endothelial Nitric Oxide Synthase–Deficient Mice | 139 |
Prevention of Aortic Fibrosis by Spironolactone in Spontaneously Hypertensive Rats | 138 |
Factor V and Thrombotic Disease | 138 |
C-Reactive Protein as a Screening Test for Cardiovascular Risk in a Multiethnic Population | 138 |
Homocysteine-Induced Inhibition of Endothelium-Dependent Relaxation in Rabbit Aorta | 138 |
Hydrogen Peroxide | 138 |
Calcification of Advanced Atherosclerotic Lesions in the Innominate Arteries of ApoE-Deficient Mice | 138 |
Functional Effects of the ABO Locus Polymorphism on Plasma Levels of von Willebrand Factor, Factor VIII, and Activated Partial Thromboplastin Time | 138 |
The Reactive Adventitia | 137 |
Infection and Inflammation Induce LDL Oxidation In Vivo | 137 |
Fenofibrate Reduces Plasma Cholesteryl Ester Transfer From HDL to VLDL and Normalizes the Atherogenic, Dense LDL Profile in Combined Hyperlipidemia | 137 |
Soluble Cell Adhesion Molecules in Hypertriglyceridemia and Potential Significance on Monocyte Adhesion | 137 |
Decreased Atherosclerosis in Low-Density Lipoprotein Receptor Knockout Mice Transplanted With
Abcg1
−/−
Bone Marrow | 137 |
Clinical and Biochemical Results of the Metalloproteinase Inhibition with Subantimicrobial Doses of Doxycycline to Prevent Acute Coronary Syndromes (MIDAS) Pilot Trial | 137 |
Increased Expression of Lectinlike Oxidized Low Density Lipoprotein Receptor-1 in Initial Atherosclerotic Lesions of Watanabe Heritable Hyperlipidemic Rabbits | 137 |
Gender Differences in Experimental Aortic Aneurysm Formation | 137 |
Osteopontin Deficiency Attenuates Atherosclerosis in Female Apolipoprotein E–Deficient Mice | 137 |
Vitamin C and E Intake Is Associated With Increased Paraoxonase Activity | 137 |
Enhanced T-Cell Expression of RANK Ligand in Acute Coronary Syndrome | 137 |
Superoxide Generation in Directional Coronary Atherectomy Specimens of Patients With Angina Pectoris | 137 |
Obesity and Oxidative Stress | 136 |
Apolipoprotein A5
, a Newly Identified Gene That Affects Plasma Triglyceride Levels in Humans and Mice | 136 |
Gender Difference in Postprandial Lipemia | 136 |
Rho-Kinase Is Involved in Macrophage-Mediated Formation of Coronary Vascular Lesions in Pigs In Vivo | 136 |
Nrf2 Gene Transfer Induces Antioxidant Enzymes and Suppresses Smooth Muscle Cell Growth In Vitro and Reduces Oxidative Stress in Rabbit Aorta In Vivo | 136 |
ADP Receptors and Clinical Bleeding Disorders | 135 |
Hyperlipidemia Promotes Osteoclastic Potential of Bone Marrow Cells Ex Vivo | 135 |
Tumor Necrosis Factor-α Promotes Macrophage-Induced Vascular Smooth Muscle Cell Apoptosis by Direct and Autocrine Mechanisms | 135 |
Hyperinsulinemia Is Associated With Increased Production Rate of Intestinal Apolipoprotein B-48–Containing Lipoproteins in Humans | 135 |
Enhanced Fatty Streak Formation in C57BL/6J Mice by Immunization With Heat Shock Protein-65 | 135 |
No Association Between Plasma Levels of Plant Sterols and Atherosclerosis in Mice and Men | 135 |
Peroxisome Proliferator-Activated Receptor γ Ligands Stimulate Endothelial Nitric Oxide Production Through Distinct Peroxisome Proliferator-Activated Receptor γ–Dependent Mechanisms | 135 |
Docosahexaenoic Acid Selectively Attenuates Induction of Vascular Cell Adhesion Molecule–1 and Subsequent Monocytic Cell Adhesion to Human Endothelial Cells Stimulated by Tumor Necrosis Factor–α | 135 |
Cholesterol Depletion Disrupts Caveolae and Differentially Impairs Agonist-Induced Arterial Contraction | 134 |
Regression of Atherosclerosis in Female Monkeys | 134 |
Hormone Replacement Therapy, Inflammation, and Hemostasis in Elderly Women | 134 |
C-Reactive Protein Is Independently Associated With Fasting Insulin in Nondiabetic Women | 134 |
FXR Deficiency Causes Reduced Atherosclerosis in
Ldlr
−/−
Mice | 134 |
Novel Candidate Genes in Unstable Areas of Human Atherosclerotic Plaques | 134 |
Role of Lipids in Osteoporosis | 133 |
Human Monocytes/Macrophages Release TNF-α in Response to Ox-LDL | 133 |
Monocyte Recruitment and Neointimal Hyperplasia in Rabbits | 133 |
Peripheral Blood Mononuclear Phagocyte Subpopulations as Cellular Markers in Hypercholesterolemia | 133 |
NO Inhibits Cytokine-Induced iNOS Expression and NF-κB Activation by Interfering With Phosphorylation and Degradation of IκB-α | 133 |
Circulating Leukocyte-Derived Microparticles Predict Subclinical Atherosclerosis Burden in Asymptomatic Subjects | 133 |
Enhanced In Vivo Lipid Peroxidation at Elevated Plasma Total Homocysteine Levels | 133 |
Relation Between Plasma Tumor Necrosis Factor-α and Insulin Sensitivity in Elderly Men With Non–Insulin-Dependent Diabetes Mellitus | 133 |
Triglycerides Are Major Determinants of Cholesterol Esterification/Transfer and HDL Remodeling in Human Plasma | 133 |
Autoantibodies Against Oxidized Low Density Lipoprotein in Patients With Angiographically Verified Coronary Artery Disease | 133 |
Macrophage ATP-Binding Cassette Transporter A1 Overexpression Inhibits Atherosclerotic Lesion Progression in Low-Density Lipoprotein Receptor Knockout Mice | 133 |
Close Approximation of Two Platelet Factor 4 Tetramers by Charge Neutralization Forms the Antigens Recognized by HIT Antibodies | 133 |
Tissue Factor–Factor VIIa Signaling | 132 |
Effects of Fluvastatin on Leukocyte–Endothelial Cell Adhesion in Hypercholesterolemic Rats | 132 |
Genetic Polymorphism of Paraoxonase and the Risk of Coronary Heart Disease | 132 |
Nitric Oxide Protects Against Leukocyte-Endothelium Interactions in the Early Stages of Hypercholesterolemia | 132 |
Binding and Internalization of C-Reactive Protein by Fcgamma Receptors on Human Aortic Endothelial Cells Mediates Biological Effects | 132 |
The Sphingosine-1-Phosphate Analogue FTY720 Reduces Atherosclerosis in Apolipoprotein E–Deficient Mice | 132 |
Plasma PAI-1 Levels Are More Strongly Related to Liver Steatosis Than to Adipose Tissue Accumulation | 132 |
Vitamin E Inhibits Abdominal Aortic Aneurysm Formation in Angiotensin II–Infused Apolipoprotein E–Deficient Mice | 132 |
Mass-Spectrometric Identification of a Novel Angiotensin Peptide in Human Plasma | 132 |
Plasma Levels of Tissue Plasminogen Activator/Plasminogen Activator Inhibitor-1 Complex and von Willebrand Factor Are Significant Risk Markers for Recurrent Myocardial Infarction in the Stockholm Hear | 131 |
Combinatorial Control of Smooth Muscle–Specific Gene Expression | 131 |
Chondrogenesis Mediated by PP
i
Depletion Promotes Spontaneous Aortic Calcification in NPP1−/− Mice | 131 |
Identification of Soluble Forms of Lectin-Like Oxidized LDL Receptor-1 | 131 |
Extracellular Signal-Regulated Kinase–Dependent Stabilization of Hepatic Low-Density Lipoprotein Receptor mRNA by Herbal Medicine Berberine | 131 |
Plasma LDL and HDL Subspecies Are Heterogenous in Particle Content of Tocopherols and Oxygenated and Hydrocarbon Carotenoids | 131 |
Bone Marrow Transplantation Reveals That Recipient AT1a Receptors Are Required to Initiate Angiotensin II–Induced Atherosclerosis and Aneurysms | 131 |
Lipoprotein Lipase Mass and Activity in Plasma and Their Increase After Heparin Are Separate Parameters With Different Relations to Plasma Lipoproteins | 131 |
Modulation of Lipoprotein B Binding to the LDL Receptor by Exogenous Lipids and Apolipoproteins CI, CII, CIII, and E | 131 |
Molecular Regulation of the Bovine Endothelial Cell Nitric Oxide Synthase by Transforming Growth Factor–β
1 | 131 |
Vascular Endothelial Growth Factor–Regulated Gene Expression in Endothelial Cells | 131 |
Comparison of Circulating Adiponectin and Proinflammatory Markers Regarding Their Association With Metabolic Syndrome in Japanese Men | 131 |
Factors Influencing the Ability of HDL to Inhibit Expression of Vascular Cell Adhesion Molecule-1 in Endothelial Cells | 131 |
Peripheral Vascular Endothelial Dysfunction and Apoptosis in Old Monkeys | 131 |
Dietary Monounsaturated Fatty Acids Promote Aortic Atherosclerosis in LDL Receptor–Null, Human ApoB100–Overexpressing Transgenic Mice | 130 |
Peroxisome Proliferator-Activated Receptor α Agonists Increase Nitric Oxide Synthase Expression in Vascular Endothelial Cells | 130 |
Intravenous Injection of Rabbit Apolipoprotein A-I Inhibits the Progression of Atherosclerosis in Cholesterol-Fed Rabbits | 130 |
Sphingosine-1-Phosphate Stimulates the Functional Capacity of Progenitor Cells by Activation of the CXCR
4
-Dependent Signaling Pathway via the S1P
| 130 |
Proatherosclerotic Mechanisms Involving Protein Kinase C in Diabetes and Insulin Resistance | 130 |
Antibodies to Periodontal Pathogens Are Associated With Coronary Heart Disease | 130 |
Inhibition of Triglyceride Synthesis as a Treatment Strategy for Obesity | 130 |
Effects of Androgens on Coronary Artery Atherosclerosis and Atherosclerosis-Related Impairment of Vascular Responsiveness | 129 |
Systemic Endothelial Dysfunction as an Early Predictor of Adverse Outcome in Heart Failure | 129 |
Network of Vascular-Associated Dendritic Cells in Intima of Healthy Young Individuals | 129 |
Statins Decrease Toll-Like Receptor 4 Expression and Downstream Signaling in Human CD14
+
Monocytes | 129 |
Reactive Oxygen Species Are Involved in Shear Stress-Induced Intercellular Adhesion Molecule-1 Expression in Endothelial Cells | 129 |
Importance of a Novel Oxidative Mechanism for Elimination of Intracellular Cholesterol in Humans | 129 |
p47phox Associates With the Cytoskeleton Through Cortactin in Human Vascular Smooth Muscle Cells | 129 |
A Prospective Case-Control Study of Lipoprotein(a) Levels and Apo(a) Size and Risk of Coronary Heart Disease in Stanford Five-City Project Participants | 129 |
The Relationship of Fibrinogen and Factors VII and VIII to Incident Cardiovascular Disease and Death in the Elderly | 129 |
Curcuma longa
Extract Supplementation Reduces Oxidative Stress and Attenuates Aortic Fatty Streak Development in Rabbits | 129 |
Adiponectin Acts as an Endogenous Antithrombotic Factor | 129 |
Uterine Spiral Artery Remodeling Involves Endothelial Apoptosis Induced by Extravillous Trophoblasts Through Fas/FasL Interactions | 129 |
Role of ADAMTS-1 in Atherosclerosis | 129 |
The Molecular Basis of Lecithin:Cholesterol Acyltransferase Deficiency Syndromes | 129 |
Lipoprotein Apheresis for Lipoprotein(a)-Associated Cardiovascular Disease | 129 |
What Is So Special About Apolipoprotein AI in Reverse Cholesterol Transport? | 128 |
Infection and Atherosclerosis | 128 |
Interleukin-6 −174G>C Polymorphism and Risk of Coronary Heart Disease in West of Scotland Coronary Prevention Study (WOSCOPS) | 128 |
The Role of Triglyceride-Rich Lipoprotein Families in the Progression of Atherosclerotic Lesions as Determined by Sequential Coronary Angiography From a Controlled Clinical Trial | 128 |
Association Between 5-Lipoxygenase Expression and Plaque Instability in Humans | 128 |
Endotoxin and Cytokines Increase Hepatic Sphingolipid Biosynthesis and Produce Lipoproteins Enriched in Ceramides and Sphingomyelin | 128 |
Venous Thrombosis–Associated Inflammation and Attenuation With Neutralizing Antibodies to Cytokines and Adhesion Molecules | 128 |
Tissue-Engineered Blood Vessels | 127 |
Modulation of Hepatic Inflammatory Risk Markers of Cardiovascular Diseases by PPAR–α Activators | 127 |
Mechanisms of Renal Structural Alterations in Combined Hypercholesterolemia and Renal Artery Stenosis | 127 |
Effects of Pioglitazone on Lipoproteins, Inflammatory Markers, and Adipokines in Nondiabetic Patients with Metabolic Syndrome | 127 |
TWEAK Is an Endothelial Cell Growth and Chemotactic Factor That Also Potentiates FGF-2 and VEGF-A Mitogenic Activity | 127 |
Common Variants in the Promoter of the Hepatic Lipase Gene Are Associated With Lower Levels of Hepatic Lipase Activity, Buoyant LDL, and Higher HDL
2
Cholesterol | 127 |
Differential Effects of Oral and Transdermal Estrogen/Progesterone Regimens on Sensitivity to Activated Protein C Among Postmenopausal Women | 127 |
No Effect of Consumption of Green and Black Tea on Plasma Lipid and Antioxidant Levels and on LDL Oxidation in Smokers | 127 |
Functional Interplay Between Angiotensin II and Nitric Oxide | 126 |
Isolation of “Side Population” Progenitor Cells From Healthy Arteries of Adult Mice | 126 |
Increased LDL Cholesterol and Atherosclerosis in LDL Receptor–Deficient Mice With Attenuated Expression of Scavenger Receptor B1 | 126 |
Regulation of Plasma High-Density Lipoprotein Levels by the ABCA1 Transporter and the Emerging Role of High-Density Lipoprotein in the Treatment of Cardiovascular Disease | 126 |
Advanced Oxidation Protein Products Accelerate Atherosclerosis Through Promoting Oxidative Stress and Inflammation | 126 |
New Functional Promoter Polymorphism, CETP/−629, in Cholesteryl Ester Transfer Protein (CETP) Gene Related to CETP Mass and High Density Lipoprotein Cholesterol Levels | 126 |
Value of HDL Cholesterol, Apolipoprotein A-I, Lipoprotein A-I, and Lipoprotein A-I/A-II in Prediction of Coronary Heart Disease | 126 |
Angiotensin II Attenuates Endothelium-Dependent Responses in the Cerebral Microcirculation Through Nox-2–Derived Radicals | 125 |
Human Paraoxonase-1 Overexpression Inhibits Atherosclerosis in a Mouse Model of Metabolic Syndrome | 125 |
Macrophages Isolated From Human Atherosclerotic Plaques Produce IL-8, and Oxysterols May Have a Regulatory Function for IL-8 Production | 125 |
C-Reactive Protein–Induced In Vitro Endothelial Cell Activation Is an Artefact Caused by Azide and Lipopolysaccharide | 125 |
Hypoadiponectinemia Is Associated With Ischemic Cerebrovascular Disease | 125 |
Flow-Mediated Dilatation Is Impaired by a High–Saturated Fat Diet but Not by a High-Carbohydrate Diet | 125 |
Adipocyte Differentiation-Related Protein Promotes Fatty Acid Storage in Cytosolic Triglycerides and Inhibits Secretion of Very Low–Density Lipoproteins | 125 |
Induction of Atherosclerosis by Low-Fat, Semisynthetic Diets in LDL Receptor–Deficient C57BL/6J and FVB/NJ Mice | 125 |
Connective Tissue Growth Factor | 124 |
Vascular Injury Induces Expression of Periostin | 124 |
Minimally Oxidized Low-Density Lipoprotein Increases Expression of Scavenger Receptor A, CD36, and Macrosialin in Resident Mouse Peritoneal Macrophages | 124 |
Hypoxia/Hypoxemia-Induced Activation of the Procoagulant Pathways and the Pathogenesis of Ischemia-Associated Thrombosis | 124 |
Iron Overload Augments the Development of Atherosclerotic Lesions in Rabbits | 124 |
Cortical Microvascular Remodeling in the Stenotic Kidney | 124 |
Hypoxia Converts Human Macrophages Into Triglyceride-Loaded Foam Cells | 124 |
Childhood C-Reactive Protein in Predicting CRP and Carotid Intima-Media Thickness in Adulthood | 124 |
Heme Oxygenase-1 Gene Promoter Polymorphism Is Associated With Coronary Artery Disease in Japanese Patients With Coronary Risk Factors | 124 |
Electron Spin Resonance Detection of Hydrogen Peroxide as an Endothelium-Derived Hyperpolarizing Factor in Porcine Coronary Microvessels | 124 |
C-Reactive Protein, Fibrin D-Dimer, and Incident Ischemic Heart Disease in the Speedwell Study | 124 |
Increase of Vitamin E Content in LDL and Reduction of Atherosclerosis in Cholesterol-Fed Rabbits by a Water-Soluble Antioxidant-Rich Fraction of
Salvia miltiorrhiza | 124 |
Associations of HDL
2
and HDL
3
Subfractions With Ischemic Heart Disease in Men | 124 |
Porphyromonas gingivalis
Bacteremia Induces Coronary and Aortic Atherosclerosis in Normocholesterolemic and Hypercholesterolemic Pigs | 124 |
Development of an Animal Model for Spontaneous Myocardial Infarction (WHHLMI Rabbit) | 123 |
Plasminogen Activator Expression in Human Atherosclerotic Lesions | 123 |
Relationships of Cerebral MRI Findings to Ultrasonographic Carotid Atherosclerosis in Older Adults | 123 |
Repetitive Fluctuations in Blood Glucose Enhance Monocyte Adhesion to the Endothelium of Rat Thoracic Aorta | 123 |
Bone Marrow–Derived Monocyte Chemoattractant Protein-1 Receptor CCR2 Is Critical in Angiotensin II–Induced Acceleration of Atherosclerosis and Aneurysm Formation in Hypercholesterolemic Mice | 123 |
CD36, a Novel Receptor for Oxidized Low-Density Lipoproteins, Is Highly Expressed on Lipid-Laden Macrophages in Human Atherosclerotic Aorta | 123 |
Arterial Compliance in Obese Subjects Is Improved With Dietary Plant n-3 Fatty Acid From Flaxseed Oil Despite Increased LDL Oxidizability | 123 |
Polymorphisms of the Interleukin-1β Gene Affect the Risk of Myocardial Infarction and Ischemic Stroke at Young Age and the Response of Mononuclear Cells to Stimulation In Vitro | 123 |
Genetic Determinants of Arterial Thrombosis | 122 |
Detection, Quantification, and Characterization of Potentially Atherogenic Triglyceride-Rich Remnant Lipoproteins | 122 |
Ultrasound and Lipoproteins as Predictors of Lipid-Rich, Rupture-Prone Plaques in the Carotid Artery | 122 |
Stem Cell Transplantation Reveals That Absence of Macrophage CD36 Is Protective Against Atherosclerosis | 122 |
Probucol Inhibits ABCA1-Mediated Cellular Lipid Efflux | 122 |
Oxidized Low Density Lipoproteins in Patients With Transplant-Associated Coronary Artery Disease | 122 |
Decoding Transcriptional Programs Regulated by PPARs and LXRs in the Macrophage | 122 |
Lipoprotein Subclasses in the Monitored Atherosclerosis Regression Study (MARS) | 122 |
Crystallization of Free Cholesterol in Model Macrophage Foam Cells | 122 |
Local Hypomethylation in Atherosclerosis Found in Rabbit
ec-sod
Gene | 122 |
Human Serum Paraoxonase 1 Decreases Macrophage Cholesterol Biosynthesis | 122 |
Impact of Short-Term Administration of High-Density Lipoproteins and Atorvastatin on Atherosclerosis in Rabbits | 122 |
Cross-Reactive B-Cell Epitopes of Microbial and Human Heat Shock Protein 60/65 in Atherosclerosis | 122 |
Long Pentraxin PTX3 Upregulates Tissue Factor Expression in Human Endothelial Cells | 122 |
Effects of Intracellular Free Cholesterol Accumulation on Macrophage Viability | 122 |
Purification, Properties, Sequencing, and Cloning of a Lipoprotein-Associated, Serine-Dependent Phospholipase Involved in the Oxidative Modification of Low-Density Lipoproteins | 122 |
Haptoglobin Genotype Is a Determinant of Iron, Lipid Peroxidation, and Macrophage Accumulation in the Atherosclerotic Plaque | 122 |
White Blood Cell Count and the Risk of Coronary Heart Disease and All-Cause Mortality in Elderly Men | 121 |
TNF-α Contributes to Endothelial Dysfunction in Ischemia/Reperfusion Injury | 121 |
The Effect of Supplementation With Omega-3 Fatty Acids on Soluble Markers of Endothelial Function in Patients With Coronary Heart Disease | 121 |
Diabetes Mellitus | 121 |
Very-Low-Density Lipoprotein Response Element in the Promoter Region of the Human Plasminogen Activator Inhibitor-1 Gene Implicated in the Impaired Fibrinolysis of Hypertriglyceridemia | 121 |
Mouse Macrophage Paraoxonase 2 Activity Is Increased Whereas Cellular Paraoxonase 3 Activity Is Decreased Under Oxidative Stress | 121 |
Parathyroid Hormone–Related Peptide as a Local Regulator of Vascular Calcification | 121 |
Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines | 121 |
High Levels of Lp(a) With a Small Apo(a) Isoform Are Associated With Coronary Artery Disease in African American and White Men | 121 |
Thrombin Activates Factor XI on Activated Platelets in the Absence of Factor XII | 120 |
LOX-1, an Oxidized LDL Endothelial Receptor, Induces CD40/CD40L Signaling in Human Coronary Artery Endothelial Cells | 120 |
Lipoprotein Lipase S447X | 120 |
Leukocyte-Derived Interleukin 10 Is Required for Protection Against Atherosclerosis in Low-Density Lipoprotein Receptor Knockout Mice | 120 |
Metabolic Basis of Hypotriglyceridemic Effects of Insulin in Normal Men | 120 |
Two Alleles of the Human Paraoxonase Gene Produce Different Amounts of mRNA | 120 |
HDL Phospholipid Content and Composition as a Major Factor Determining Cholesterol Efflux Capacity From Fu5AH Cells to Human Serum | 120 |
Carotid Plaque Composition Differs Between Ethno-Racial Groups | 120 |
Increased Blood Flow Induces Regression of Intimal Hyperplasia | 119 |
Adiponectin and Coronary Heart Disease: The Strong Heart Study | 119 |
Human Urotensin II Is a Novel Activator of NADPH Oxidase in Human Pulmonary Artery Smooth Muscle Cells | 119 |
The Gln-Arg192 Polymorphism of Human Paraoxonase Gene Is Not Associated With Coronary Artery Disease in Italian Patients | 119 |
Perivascular Adipose Tissue and Mesenteric Vascular Function in Spontaneously Hypertensive Rats | 119 |
Linked Chromosome 16q13 Chemokines, Macrophage-Derived Chemokine, Fractalkine, and Thymus- and Activation-Regulated Chemokine, Are Expressed in Human Atherosclerotic Lesions | 119 |
Oxidized LDL Regulates Vascular Endothelial Growth Factor Expression in Human Macrophages and Endothelial Cells Through Activation of Peroxisome Proliferator–Activated Receptor-γ | 119 |
Adrenomedullin | 118 |
Novel Vascular Biology of Third-Generation L-Type Calcium Channel Antagonists | 118 |
Regulation of Monocyte CD36 and Thrombospondin-1 Expression by Soluble Mediators | 118 |
Angiotensin II Type 1 Receptor Antagonism Improves Hypercholesterolemia-Associated Endothelial Dysfunction | 118 |
Lymphocyte Populations in Atherosclerotic Lesions of ApoE −/− and LDL Receptor −/− Mice | 118 |
Chemokine Receptor CCR2 Expression and Monocyte Chemoattractant Protein-1–Mediated Chemotaxis in Human Monocytes | 118 |
Can Exercise Training With Weight Loss Lower Serum C-Reactive Protein Levels? | 118 |
Androgen Deprivation Is Associated With Enhanced Endothelium-Dependent Dilatation in Adult Men | 118 |
Carbon Monoxide Protects Against Cardiac Ischemia—Reperfusion Injury In Vivo via MAPK and Akt—eNOS Pathways | 118 |
Adipocyte Fatty Acid–Binding Protein Expression and Lipid Accumulation Are Increased During Activation of Murine Macrophages by Toll-Like Receptor Agonists | 118 |
Change in α
1
HDL Concentration Predicts Progression in Coronary Artery Stenosis | 118 |
Endothelial Dysfunction and Low-Grade Inflammation Explain Much of the Excess Cardiovascular Mortality in Individuals With Type 2 Diabetes | 118 |
D-4F and Statins Synergize to Render HDL Antiinflammatory in Mice and Monkeys and Cause Lesion Regression in Old Apolipoprotein E–Null Mice | 118 |
Atherosclerotic Disease in Marked Hyperalphalipoproteinemia | 118 |
Matrix Metalloproteinase Inhibition Attenuates Aortic Calcification | 117 |
Mineral Exploration: Search for the Mechanism of Vascular Calcification and Beyond | 117 |
Antagonistic Effects of 17β-Estradiol, Progesterone, and Testosterone on Ca
2+
Entry Mechanisms of Coronary Vasoconstriction | 117 |
Lack of Interleukin-1 Receptor Antagonist Modulates Plaque Composition in Apolipoprotein E–Deficient Mice | 117 |
Cosupplementation With Coenzyme Q Prevents the Prooxidant Effect of α-Tocopherol and Increases the Resistance of LDL to Transition Metal–Dependent Oxidation Initiation | 117 |
Simvastatin Modulates Expression of the
PON1
Gene and Increases Serum Paraoxonase | 117 |
Apolipoprotein Concentrations During Treatment and Recurrent Coronary Artery Disease Events | 117 |
Effects of Long-Term Daily Low-Dose Supplementation With Antioxidant Vitamins and Minerals on Structure and Function of Large Arteries | 117 |
Inflammatory Mediators and Cell Adhesion Molecules as Indicators of Severity of Atherosclerosis | 117 |
Smooth Muscle Cell Phenotypic Diversity | 117 |
Inhibition of Neointima Formation by a Novel Drug-Eluting Stent System That Allows for Dose-Adjustable, Multiple, and On-Site Stent Coating | 117 |
Detection of Osteopontin in Calcified Human Aortic Valves | 116 |
Contrary Effects of Lightly and Strongly Oxidized LDL With Potent Promotion of Growth Versus Apoptosis on Arterial Smooth Muscle Cells, Macrophages, and Fibroblasts | 116 |
Role of Mitochondrial Oxidant Generation in Endothelial Cell Responses to Hypoxia | 116 |
Heterogeneity of Smooth Muscle Cell Populations Cultured From Pig Coronary Artery | 116 |
Impaired Superoxide Production Due to a Deficiency in Phagocyte NADPH Oxidase Fails to Inhibit Atherosclerosis in Mice | 116 |
Improvement of Collateral Perfusion and Regional Function by Implantation of Peripheral Blood Mononuclear Cells Into Ischemic Hibernating Myocardium | 116 |
Abdominal Aortic Aneurysm Rupture Is Associated With Increased Medial Neovascularization and Overexpression of Proangiogenic Cytokines | 116 |
Regulation of Lipoprotein Metabolism by Thiazolidinediones Occurs through a Distinct but Complementary Mechanism Relative to Fibrates | 116 |
Localization of Nonpancreatic Secretory Phospholipase A
2
in Normal and Atherosclerotic Arteries | 116 |
Both Raloxifene and Estrogen Reduce Major Cardiovascular Risk Factors in Healthy Postmenopausal Women | 116 |
Endothelial Nitric Oxide Synthase Activation by Tumor Necrosis Factor α Through Neutral Sphingomyelinase 2, Sphingosine Kinase 1, and Sphingosine 1 Phosphate Receptors | 116 |
Plasma Thrombin-Activatable Fibrinolysis Inhibitor Antigen Concentration and Genotype in Relation to Myocardial Infarction in the North and South of Europe | 116 |
Signaling in Leukocyte Transendothelial Migration | 115 |
Regression or Progression | 115 |
ABCA1-Deficient Mice | 115 |
Simvastatin Promotes Atherosclerotic Plaque Stability in ApoE-Deficient Mice Independently of Lipid Lowering | 115 |
Adoptive Transfer of CD4
+
T Cells Reactive to Modified Low-Density Lipoprotein Aggravates Atherosclerosis | 115 |
Rapid Perfusion and Network Remodeling in a Microvascular Construct After Implantation | 115 |
New Insights Into the Role of Lipoprotein(a)-Associated Lipoprotein-Associated Phospholipase A
2
in Atherosclerosis and Cardiovascular Disease | 115 |
Number and Adhesive Properties of Circulating Endothelial Progenitor Cells in Patients With In-Stent Restenosis | 115 |
Critical Role of Rho-Kinase and MEK/ERK Pathways for Angiotensin II–Induced Plasminogen Activator Inhibitor Type-1 Gene Expression | 115 |
Expression of ACAT-1 Protein in Human Atherosclerotic Lesions and Cultured Human Monocytes-Macrophages | 115 |
Epidemiology of Vascular Dementia | 115 |
Trichostatin A Exacerbates Atherosclerosis in Low Density Lipoprotein Receptor–Deficient Mice | 115 |
Analysis of Coagulation Cascade and Endothelial Cell Activation During Inhibition of Vascular Endothelial Growth Factor/Vascular Endothelial Growth Factor Receptor Pathway in Cancer Patients | 115 |
Mouse Model of Femoral Artery Denudation Injury Associated With the Rapid Accumulation of Adhesion Molecules on the Luminal Surface and Recruitment of Neutrophils | 115 |
Selective Blockade of the Intermediate-Conductance Ca
2+
-Activated K
+
Channel Suppresses Proliferation of Microvascular and Macr | 115 |
Cholesteryl Ester Transfer Protein
Taq
I B2B2 Genotype Is Associated With Higher HDL Cholesterol Levels and Lower Risk of Coronary Hea | 115 |
Molecular Basis of Platelet Granule Secretion | 114 |
Endothelial Nitric Oxide Synthase | 114 |
MRI and Characterization of Atherosclerotic Plaque | 114 |
Uncoupling of Endothelial Nitric Oxidase Synthase by Hypochlorous Acid | 114 |
Controlled Trial of α-Tocopherol and β-Carotene Supplements on Stroke Incidence and Mortality in Male Smokers | 114 |
Type 2 Diabetic Mice Have Increased Arteriolar Tone and Blood Pressure | 114 |
Reactive Oxygen Species Mediate Endothelium-Dependent Relaxations in Tetrahydrobiopterin-Deficient Mice | 114 |
Risk of Venous Thromboembolism and Clinical Manifestations in Carriers of Antithrombin, Protein C, Protein S Deficiency, or Activated Protein C Resistance | 114 |
Regulation of Functions of Vascular Wall Cells by Tissue Factor Pathway Inhibitor | 113 |
Interaction Between the G20210A Mutation of the Prothrombin Gene and Oral Contraceptive Use in Deep Vein Thrombosis | 113 |
Protection of Endothelial Survival by Peroxisome Proliferator-Activated Receptor-δ Mediated 14-3-3 Upregulation | 113 |
Vascular Dysfunction and Reduced Circulating Endothelial Progenitor Cells in Young Healthy UK South Asian Men | 113 |
Applications of Nanotechnology to Atherosclerosis, Thrombosis, and Vascular Biology | 112 |
Physiological Increments in Plasma Homocysteine Induce Vascular Endothelial Dysfunction in Normal Human Subjects | 112 |
Decreased Serum Testosterone in Men With Acute Ischemic Stroke | 112 |
Tumor Necrosis Factor-α Activates Smooth Muscle Cell Migration in Culture and Is Expressed in the Balloon-Injured Rat Aorta | 112 |
Oxidized Phospholipids Trigger Atherogenic Inflammation in Murine Arteries | 112 |
Influence of Folic Acid on Postprandial Endothelial Dysfunction | 112 |
Adaptive Remodeling of Internal Elastic Lamina and Endothelial Lining During Flow-Induced Arterial Enlargement | 112 |
Coronary and Aortic Calcification Among Women 8 Years After Menopause and Their Premenopausal Risk Factors | 112 |
Reduced Atherosclerotic Lesions in Mice Deficient for Total or Macrophage-Specific Expression of Scavenger Receptor-A | 112 |
Clinical Studies and Thrombin Generation in Patients Homozygous or Heterozygous for the G20210A Mutation in the Prothrombin Gene | 112 |
Ginkgo biloba
Extract Inhibits Tumor Necrosis Factor-α–Induced Reactive Oxygen Species Generation, Transcription Factor Activation, and Cell Adhesion Molecule Expression in Human Ao | 112 |
ICAM-1 Deficiency Reduces Atherosclerotic Lesions in Double-Knockout Mice (ApoE
−
/−
/ICAM-1
−
/− | 112 |
Suppression of Rage as a Basis of Simvastatin-Dependent Plaque Stabilization in Type 2 Diabetes | 112 |
Increased Concentrations of C-Reactive Protein and IL-6 but not IL-18 Are Independently Associated With Incident Coronary Events in Middle-Aged Men and Women | 112 |
The Natural Course of Atherosclerosis | 111 |
Cellular Senescence After Single and Repeated Balloon Catheter Denudations of Rabbit Carotid Arteries | 111 |
Cerebrovascular Nitrosative Stress Mediates Neurovascular and Endothelial Dysfunction Induced by Angiotensin II | 111 |
Activation of Mitogen-Activated Protein Kinases (ERK/JNK) and AP-1 Transcription Factor in Rat Carotid Arteries After Balloon Injury | 111 |
Statins Inhibit Synthesis of an Oxysterol Ligand for the Liver X Receptor in Human Macrophages With Consequences for Cholesterol Flux | 111 |
Serum Antibody Levels to
Actinobacillus actinomycetemcomitans
Predict the Risk for Coronary Heart Disease | 111 |
Effect of Immune Deficiency on Lipoproteins and Atherosclerosis in Male Apolipoprotein E–Deficient Mice | 111 |
Correlation Between Flow-Mediated Vasodilatation of the Brachial Artery and Intima-Media Thickness in the Carotid Artery in Men | 111 |
A New Promoter Polymorphism in the Gene of Lipopolysaccharide Receptor CD14 Is Associated With Expired Myocardial Infarction in Patients With Low Atherosclerotic Risk Profile | 111 |
Differentiation of Smooth Muscle Cells in Human Blood Vessels as Defined by Smoothelin, a Novel Marker for the Contractile Phenotype | 111 |
Nebivolol Prevents Vascular NOS III Uncoupling in Experimental Hyperlipidemia and Inhibits NADPH Oxidase Activity in Inflammatory Cells | 111 |
The Roles of Proteinase-Activated Receptors in the Vascular Physiology and Pathophysiology | 110 |
Statin Therapy in Acute Coronary Syndromes | 110 |
Elastogenesis in Human Arterial Disease | 110 |
Liver X Receptor Agonists as Potential Therapeutic Agents for Dyslipidemia and Atherosclerosis | 110 |
Extracellular Proteases in Atherosclerosis and Restenosis | 110 |
Imatinib Attenuates Diabetes-Associated Atherosclerosis | 110 |
Rapid Effects of Rosiglitazone Treatment on Endothelial Function and Inflammatory Biomarkers | 110 |
Megakaryocyte Ploidy and Platelet Changes in Human Diabetes and Atherosclerosis | 110 |
Oxidized LDLs Induce Massive Apoptosis of Cultured Human Endothelial Cells Through a Calcium-Dependent Pathway | 110 |
Immunohistochemical Demonstration of Enzymatically Modified Human LDL and Its Colocalization With the Terminal Complement Complex in the Early Atherosclerotic Lesion | 110 |
Fibrin and Activated Platelets Cooperatively Guide Stem Cells to a Vascular Injury and Promote Differentiation Towards an Endothelial Cell Phenotype | 110 |
Hyperhomocystinemia Impairs Endothelial Function and eNOS Activity via PKC Activation | 110 |
Decreased Protection by HDL From Poorly Controlled Type 2 Diabetic Subjects Against LDL Oxidation May Be Due to the Abnormal Composition of HDL | 110 |
Anti–MCP-1 Gene Therapy Inhibits Vascular Smooth Muscle Cells Proliferation and Attenuates Vein Graft Thickening Both In Vitro and In Vivo | 110 |
Redox Modulation of Vascular Tone | 109 |
α-Tocopherol Decreases Interleukin-1β Release From Activated Human Monocytes by Inhibition of 5-Lipoxygenase | 109 |
Upregulation of Prostacyclin Synthesis–Related Gene Expression by Shear Stress in Vascular Endothelial Cells | 109 |
Platelet Rebound Effect of Alcohol Withdrawal and Wine Drinking in Rats | 109 |
Depletion of Natural Killer Cell Function Decreases Atherosclerosis in Low-Density Lipoprotein Receptor Null Mice | 109 |
Increased Monocyte Adhesion to Aortic Endothelium in Rats With Hyperhomocysteinemia | 109 |
Oxidized Phospholipid-Induced Endothelial Cell/Monocyte Interaction Is Mediated by a cAMP-Dependent R-Ras/PI3-Kinase Pathway | 109 |
Endogenous Nitric Oxide Synthesis Inhibitor Asymmetric Dimethyl
l
-Arginine Accelerates Endothelial Cell Senescence | 109 |
Antioxidative and Antiatherosclerotic Effects of Human Apolipoprotein A-IV in Apolipoprotein E–Deficient Mice | 109 |
Cyclic Stretch Upregulates Production of Interleukin-8 and Monocyte Chemotactic and Activating Factor/Monocyte Chemoattractant Protein-1 in Human Endothelial Cells | 109 |
New Insights Into the Differentiation of Megakaryocytes From Hematopoietic Progenitors | 109 |
A
192
Arg Variant of the Human Paraoxonase
(HUMPONA)
Gene Polymorphism Is Associated With an Increased Risk for Coronary Artery Diseas | 109 |
Association of High Coronary Heart Disease Risk Status With Circulating Oxidized LDL in the Well-Functioning Elderly | 109 |
Common C-to-T Substitution at Position −480 of the Hepatic Lipase Promoter Associated With a Lowered Lipase Activity in Coronary Artery Disease Patients | 109 |
Vitamin Supplementation Reduces Blood Homocysteine Levels | 109 |
α-Lipoic Acid Prevents Endothelial Dysfunction in Obese Rats via Activation of AMP-Activated Protein Kinase | 109 |
Noncollagenous Bone Matrix Proteins, Calcification, and Thrombosis in Carotid Artery Atherosclerosis | 108 |
Immunologic Detection and Measurement of Hypochlorite-Modified LDL With Specific Monoclonal Antibodies | 108 |
Phenotypic Heterogeneity of Rat Arterial Smooth Muscle Cell Clones | 108 |
High Plasma Phospholipid Transfer Protein Levels as a Risk Factor for Coronary Artery Disease | 108 |
Quantification of Postprandial Triglyceride-Rich Lipoproteins in Healthy Men by Retinyl Ester Labeling and Simultaneous Measurement of Apolipoproteins B-48 and B-100 | 108 |
Asymmetric Dimethylarginine Predicts Major Adverse Cardiovascular Events in Patients With Advanced Peripheral Artery Disease | 108 |
Gene Expression Phenotypes of Atherosclerosis | 108 |
A Common Mutation in the Methylenetetrahydrofolate Reductase Gene (C677T) Increases the Risk for Deep-Vein Thrombosis in Patients With Mutant Factor V (Factor V:Q
506
| 108 |
Insulin-Like Growth Factor Binding Protein-4 Protease Produced by Smooth Muscle Cells Increases in the Coronary Artery After Angioplasty | 108 |
Sphingosine-1-Phosphate Prevents Tumor Necrosis Factor-α–Mediated Monocyte Adhesion to Aortic Endothelium in Mice | 108 |
Cytoskeletal Effects of Rho-Like Small Guanine Nucleotide–Binding Proteins in the Vascular System | 107 |
Regulation of Fibrinolysis by Thrombin Activatable Fibrinolysis Inhibitor, an Unstable Carboxypeptidase B That Unites the Pathways of Coagulation and Fibrinolysis | 107 |
Acute Effects of Intravenous Infusion of ApoA1/Phosphatidylcholine Discs on Plasma Lipoproteins in Humans | 107 |
Plasma Viscosity and the Risk of Coronary Heart Disease | 107 |
Dimorphism in the P2Y1 ADP Receptor Gene Is Associated With Increased Platelet Activation Response to ADP | 107 |
Biologically Active CD40 Ligand Is Elevated in Sickle Cell Anemia | 107 |
Extracellular Matrix Modulates Macrophage Functions Characteristic to Atheroma | 107 |
Clopidogrel Improves Systemic Endothelial Nitric Oxide Bioavailability in Patients With Coronary Artery Disease | 107 |
Lipoprotein Lipase Gene Variation Is Associated With a Paternal History of Premature Coronary Artery Disease and Fasting and Postprandial Plasma Triglycerides | 107 |
Curcumin Inhibits Platelet-Derived Growth Factor–Stimulated Vascular Smooth Muscle Cell Function and Injury-Induced Neointima Formation | 107 |
Correlation of Vasa Vasorum Neovascularization and Plaque Progression in Aortas of Apolipoprotein E
−/−
/Low-Density Lipoprotein
−/−
| 107 |
A Novel Loss of Function Mutation of
PCSK9
Gene in White Subjects With Low-Plasma Low-Density Lipoprotein Cholesterol | 107 |
Improving Prediction of Ischemic Cardiovascular Disease in the General Population Using Apolipoprotein B | 106 |
Diabetes and Progression of Carotid Atherosclerosis | 106 |
Mechanism of Endothelial Dysfunction in Apolipoprotein E–Deficient Mice | 106 |
Association Between the PPARA L162V Polymorphism and Plasma Lipid Levels | 106 |
Atherosclerotic Plaque Rupture | 106 |
Leukotriene B
4
Strongly Increases Monocyte Chemoattractant Protein-1 in Human Monocytes | 106 |
The Heterozygous 20210 G/A Prothrombin Genotype Is Associated With Early Venous Thrombosis in Inherited Thrombophilias and Is Not Increased in Frequency in Artery Disease | 106 |
Omega-3 Fatty Acids in Adipose Tissue and Risk of Myocardial Infarction | 106 |
High-Density Lipoproteins: A New Potential Therapeutic Target for the Prevention of Cardiovascular Disease | 106 |
Physical Training Improves Flow-Mediated Dilation in Patients With the Polymetabolic Syndrome | 106 |
Genetic and Environmental Determinants of Fibrin Structure and Function | 105 |
In Vivo Imaging of Thrombin Activity in Experimental Thrombi With Thrombin-Sensitive Near-Infrared Molecular Probe | 105 |
C-Reactive Protein Alters Antioxidant Defenses and Promotes Apoptosis in Endothelial Progenitor Cells | 105 |
Dyslipidemia and Vascular Dysfunction in Diabetic Pigs Fed an Atherogenic Diet | 105 |
IQGAP1 Regulates Reactive Oxygen Species–Dependent Endothelial Cell Migration Through Interacting With Nox2 | 105 |
Prospective Evaluation of the Risk Conferred by Factor V Leiden and Thermolabile Methylenetetrahydrofolate Reductase Polymorphisms in Pregnancy | 105 |
In Situ Localization and Quantification of mRNA for 92-kD Type IV Collagenase and Its Inhibitor in Aneurysmal, Occlusive, and Normal Aorta | 105 |
Apolipoprotein A-V Deficiency Results in Marked Hypertriglyceridemia Attributable to Decreased Lipolysis of Triglyceride-Rich Lipoproteins and Removal of Their Remnants | 105 |
Simvastatin Reduces the Expression of Adhesion Molecules in Circulating Monocytes From Hypercholesterolemic Patients | 105 |
Identification of Soluble Tumor Necrosis Factor-Like Weak Inducer of Apoptosis (sTWEAK) as a Possible Biomarker of Subclinical Atherosclerosis | 105 |
Atherosclerosis in Chronic Kidney Disease | 105 |
“Tall Oil”–Derived Phytosterols Reduce Atherosclerosis in ApoE-Deficient Mice | 104 |
Coagulation Factor VII and the Risk of Coronary Heart Disease in Healthy Men | 104 |
Adiponectin Is an Important Determinant of ApoA-I Catabolism | 104 |
Simvastatin Preserves Coronary Endothelial Function in Hypercholesterolemia in the Absence of Lipid Lowering | 104 |
Group V Secretory Phospholipase A
2
Promotes Atherosclerosis | 104 |
Effects of Rosiglitazone on Lipids, Adipokines, and Inflammatory Markers in Nondiabetic Patients With Low High-Density Lipoprotein Cholesterol and Metabolic Syndrome | 104 |
Deep Vein Thrombosis Resolution Is Modulated by Monocyte CXCR2-Mediated Activity in a Mouse Model | 104 |
Platelet Activation Induces Cell-Surface Immunoreactive Tissue Factor Expression, Which Is Modulated Differently by Antiplatelet Drugs | 104 |
Hyperhomocysteinemia and Oxidative Stress | 103 |
Vascular Myofibroblasts | 103 |
Hepatic and Extrahepatic Scavenger Receptors | 103 |
Involvement of the Antimicrobial Peptide LL-37 in Human Atherosclerosis | 103 |
Deficiency of Niemann-Pick C1 Like 1 Prevents Atherosclerosis in ApoE
−/−
Mice | 103 |
Induction of Macrophage VEGF in Response to Oxidized LDL and VEGF Accumulation in Human Atherosclerotic Lesions | 103 |
Connective Tissue Growth Factor Is Overexpressed in Complicated Atherosclerotic Plaques and Induces Mononuclear Cell Chemotaxis In Vitro | 103 |
15d-Prostaglandin J
2
Protects Brain From Ischemia-Reperfusion Injury | 103 |
Differentiation, Dedifferentiation, and Apoptosis of Smooth Muscle Cells During the Development of the Human Ductus Arteriosus | 103 |
Factor V Leiden, Hormone Replacement Therapy, and Risk of Venous Thromboembolic Events in Women With Coronary Disease | 103 |
Vascular Superoxide Dismutase Deficiency Impairs Endothelial Vasodilator Function Through Direct Inactivation of Nitric Oxide and Increased Lipid Peroxidation | 103 |
Human Monocyte Heterogeneity as Revealed by High-Dimensional Mass Cytometry | 103 |
Enhanced Expression of the Homeostatic Chemokines CCL19 and CCL21 in Clinical and Experimental Atherosclerosis | 103 |
The Natural Course of Atherosclerosis | 102 |
Soluble Elastin Fragments in Serum Are Elevated in Acute Aortic Dissection | 102 |
Association Between Osteopontin and Human Abdominal Aortic Aneurysm | 102 |
Smallest LDL Particles Are Most Strongly Related to Coronary Disease Progression in Men | 102 |
RAGE Axis | 102 |
Intracellular and Surface Distribution of Monocyte Tissue Factor | 102 |
Hyperlipidemia and Atherosclerotic Lesion Development in LDL Receptor–Deficient Mice Fed Defined Semipurified Diets With and Without Cholate | 102 |
Elevated Markers of Endothelial Dysfunction Predict Type 2 Diabetes Mellitus in Middle-Aged Men and Women From the General Population | 102 |
Effects of Peroxisome Proliferator-Activated Receptor Ligands, Bezafibrate and Fenofibrate, on Adiponectin Level | 102 |
Role of Group II Secretory Phospholipase A
2
in Atherosclerosis | 102 |
Apolipoprotein E Recycling | 101 |
Oxidized LDL Stimulates Mitogen-Activated Protein Kinases in Smooth Muscle Cells and Macrophages | 101 |
Fibronectin Expression and Aortic Wall Elastic Modulus in Spontaneously Hypertensive Rats | 101 |
A Common Functional Polymorphism in the Promoter Region of the Microsomal Triglyceride Transfer Protein Gene Influences Plasma LDL Levels | 101 |
Blood Pressure Increase and Incidence of Hypertension in Relation to Inflammation-Sensitive Plasma Proteins | 101 |
Ultrasound Morphology Classification of the Arterial Wall and Cardiovascular Events in a 6-Year Follow-up Study | 101 |
PAI-1 Plasma Levels in a General Population Without Clinical Evidence of Atherosclerosis | 101 |
Increased Ratio of CD31
+
/CD42
−
Microparticles to Endothelial Progenitors as a Novel Marker of Atherosclerosis in Hypercholester | 101 |
Familial Resemblance of Plasma Lipids, Lipoproteins and Postheparin Lipoprotein and Hepatic Lipases in the HERITAGE Family Study | 101 |
Vascular Implications of the Krüppel-Like Family of Transcription Factors | 100 |
Regional Body Composition Changes Exhibit Opposing Effects on Coronary Heart Disease Risk Factors | 100 |
C-Reactive Protein Decreases Tissue Plasminogen Activator Activity in Human Aortic Endothelial Cells | 100 |
Hepatocyte Growth Factor/Scatter Factor Can Induce Angiogenesis Independently of Vascular Endothelial Growth Factor | 100 |
Advanced Glycosylation End Products Might Promote Atherosclerosis Through Inducing the Immune Maturation of Dendritic Cells | 100 |
Progression of Carotid Intima-Media Thickness and Plasma Antioxidants: The Los Angeles Atherosclerosis Study | 100 |
Prognostic Value of Abnormal Vasoreactivity of Epicardial Coronary Arteries to Sympathetic Stimulation in Patients With Normal Coronary Angiograms | 100 |
PAR-1 Activation on Human Late Endothelial Progenitor Cells Enhances Angiogenesis In Vitro With Upregulation of the SDF-1/CXCR4 System | 100 |
Caveolin-1 Is Essential for Activation of Rac1 and NAD(P)H Oxidase After Angiotensin II Type 1 Receptor Stimulation in Vascular Smooth Muscle Cells | 100 |
Adrenomedullin/Cyclic AMP Pathway Induces Notch Activation and Differentiation of Arterial Endothelial Cells From Vascular Progenitors | 100 |
Sex Differences in Visceral Fat Lipolysis and Metabolic Complications of Obesity | 99 |
Effect of Fluid Flow on Smooth Muscle Cells in a 3-Dimensional Collagen Gel Model | 99 |
CD40 Ligand Influences Platelet Release of Reactive Oxygen Intermediates | 99 |
Niacin Accelerates Intracellular ApoB Degradation by Inhibiting Triacylglycerol Synthesis in Human Hepatoblastoma (HepG2) Cells | 99 |
Heparin Inhibition of Endothelial Cell Proliferation and Organization Is Dependent on Molecular Weight | 99 |
eNOS Gene Transfer Inhibits Smooth Muscle Cell Migration and MMP-2 and MMP-9 Activity | 99 |
Intimal Retention of Cholesterol Derived From Apolipoprotein B100– and Apolipoprotein B48–Containing Lipoproteins in Carotid Arteries of Watanabe Heritable Hyperlipidemic Rabbits | 99 |
Transcriptional and Posttranscriptional Regulation of Cyclooxygenase-2 Expression by Fluid Shear Stress in Vascular Endothelial Cells | 99 |
Shear Stress as an Inhibitor of Vascular Smooth Muscle Cell Proliferation | 99 |
Changes in Ubiquitin Proteasome Pathway Gene Expression in Skeletal Muscle With Exercise and Statins | 99 |
Differential Involvement of the P2Y
1
and P2Y
12
Receptors in Platelet Procoagulant Activity | 99 |
Phenotypic Modulation of Intima and Media Smooth Muscle Cells in Fatal Cases of Coronary Artery Lesion | 99 |
Inhibition of Tissue Factor Gene Activation in Cultured Endothelial Cells by Curcumin | 99 |
Genome-Wide Linkage Analysis of the Acute Coronary Syndrome Suggests a Locus on Chromosome 2 | 99 |
Increased Circulating Malondialdehyde-Modified LDL Levels in Patients With Coronary Artery Diseases and Their Association With Peak Sizes of LDL Particles | 99 |
Genetic Background Determines the Extent of Atherosclerosis in ApoE-Deficient Mice | 99 |
Regulation of Transport of the Angiotensin AT2 Receptor by a Novel Membrane-Associated Golgi Protein | 99 |
Sca-1
+
Progenitors Derived From Embryonic Stem Cells Differentiate Into Endothelial Cells Capable of Vascular Repair After Arterial Injury | 99 |
Association of Postprandial Triglyceride and Retinyl Palmitate Responses With Asymptomatic Carotid Artery Atherosclerosis in Middle-aged Men and Women | 99 |
Effect of Oral and Transdermal Estrogen Replacement Therapy on Hemostatic Variables Associated With Venous Thrombosis | 99 |
−455G/A Polymorphism of the β-Fibrinogen Gene is Associated With the Progression of Coronary Atherosclerosis in Symptomatic Men | 99 |
A Common Variant in the Gene for Lipoprotein Lipase (Asp9→Asn) | 99 |
Tissue-Specific Hemostasis in Mice | 98 |
HIV Protease Inhibitors Stimulate Hepatic Triglyceride Synthesis | 98 |
Relationship Between Serum Sex Hormones and Coronary Artery Disease in Postmenopausal Women | 98 |
1999 George Lyman Duff Memorial Lecture | 98 |
Evidence That Peroxisome Proliferator–Activated Receptor Delta Influences Cholesterol Metabolism in Men | 98 |
Role of RhoA and Rho Kinase in Lysophosphatidic Acid–Induced Endothelial Barrier Dysfunction | 98 |
Inhibition of Arterial Thrombus Formation by ApoA1 Milano | 98 |
HMG-CoA Reductase Inhibitor Increases GTP Cyclohydrolase I mRNA and Tetrahydrobiopterin in Vascular Endothelial Cells | 98 |
Increased NAD(P)H Oxidase and Reactive Oxygen Species in Coronary Arteries After Balloon Injury | 98 |
High Plasma Serotonin Levels in Primary Pulmonary Hypertension | 98 |
Coronary Artery Disease in IDDM | 98 |
Rosiglitazone Attenuates Atherosclerosis in a Model of Insulin Insufficiency Independent of Its Metabolic Effects | 98 |
α-Lipoic Acid–Induced Heme Oxygenase-1 Expression Is Mediated by Nuclear Factor Erythroid 2-Related Factor 2 and p38 Mitogen-Activated Protein Kinase in Human Monocytic Cells | 98 |
Dietary Cosupplementation With Vitamin E and Coenzyme Q
10
Inhibits Atherosclerosis in Apolipoprotein E Gene Knockout Mice | 98 |
Genetic Analysis of the IRS | 98 |
Western-Type Diets Induce Insulin Resistance and Hyperinsulinemia in LDL Receptor-Deficient Mice But Do Not Increase Aortic Atherosclerosis Compared With Normoinsulinemic Mice in Which Similar Plasma | 98 |
Clinical Expression of Familial Hypercholesterolemia in Clusters of Mutations of the LDL Receptor Gene That Cause a Receptor-Defective or Receptor-Negative Phenotype | 98 |
Methamphetamine Use and Cardiovascular Disease | 98 |
Genetic Modifiers of Atherosclerosis in Mice | 97 |
Interleukin-8 Production by Macrophages From Atheromatous Plaques | 97 |
Exercise and Physical Activity in the Prevention and Treatment of Atherosclerotic Cardiovascular Disease | 97 |
Westernization of Chinese Adults and Increased Subclinical Atherosclerosis | 97 |
Circulating Autoantibodies to Oxidized LDL Correlate With Arterial Accumulation and Depletion of Oxidized LDL in LDL Receptor–Deficient Mice | 97 |
Selective Cyclooxygenase-2 Inhibition With Celecoxib Decreases Angiotensin II-Induced Abdominal Aortic Aneurysm Formation in Mice | 97 |
Contribution of an In Vivo Oxidized LDL to LDL Oxidation and Its Association With Dense LDL Subpopulations | 97 |
Pitavastatin-Induced Thrombomodulin Expression by Endothelial Cells Acts Via Inhibition of Small G Proteins of the Rho Family | 97 |
Interleukin-6, Fibrin D-Dimer, and Coagulation Factors VII and XIIa in Prediction of Coronary Heart Disease | 97 |
Reconstituted High-Density Lipoprotein Stimulates Differentiation of Endothelial Progenitor Cells and Enhances Ischemia-Induced Angiogenesis | 97 |
Force Sensing by Piezo Channels in Cardiovascular Health and Disease | 97 |
Human Secretory Phospholipase A
2
Mediates Decreased Plasma Levels of HDL Cholesterol and ApoA-I in Response to Inflammation in Human ApoA-I Transgenic Mice | 97 |
Paraoxonase Activity, But Not Haplotype Utilizing the Linkage Disequilibrium Structure, Predicts Vascular Disease | 97 |
High Serum Levels of Advanced Glycation End Products Predict Increased Coronary Heart Disease Mortality in Nondiabetic Women but not in Nondiabetic Men | 97 |
Platelets From a Patient Heterozygous for the Defect of P2
CYC
Receptors for ADP Have a Secretion Defect Despite Normal Thromboxane A
2
| 97 |
Cyclooxygenase-2 Expression and Inhibition in Atherothrombosis | 96 |
MnSOD Deficiency Increases Endothelial Dysfunction in ApoE-Deficient Mice | 96 |
Obesity, Peroxisome Proliferator-Activated Receptor, and Atherosclerosis in Type 2 Diabetes | 96 |
IL-18 Accelerates Atherosclerosis Accompanied by Elevation of IFN-γ and CXCL16 Expression Independently of T Cells | 96 |
Cellular Consequences of the Association of ApoB Lipoproteins With Proteoglycans | 96 |
Heme Oxygenase-1 Is a cGMP-Inducible Endothelial Protein and Mediates the Cytoprotective Action of Nitric Oxide | 96 |
Serum Lipid Levels and the Risk of Venous Thrombosis | 96 |
HIV Protease Inhibitor Ritonavir Induces Cytotoxicity of Human Endothelial Cells | 96 |
Increased Plasma 7β-Hydroxycholesterol Concentrations in a Population With a High Risk for Cardiovascular Disease | 96 |
C-Reactive Protein Inhibits Endothelium-Dependent NO-Mediated Dilation in Coronary Arterioles by Activating p38 Kinase and NAD(P)H Oxidase | 96 |
Independent Mutations at Codon 3500 of the Apolipoprotein B Gene Are Associated With Hyperlipidemia | 96 |
Oxidized LDL-Induced Smooth Muscle Cell Proliferation Involves the EGF Receptor/PI-3 Kinase/Akt and the Sphingolipid Signaling Pathways | 96 |
Expression of Fractalkine (CX3CL1) and its Receptor, CX3CR1, Is Elevated in Coronary Artery Disease and Is Reduced During Statin Therapy | 96 |
Reciprocal and Coordinate Regulation of Serum Amyloid A Versus Apolipoprotein A-I and Paraoxonase-1 by Inflammation in Murine Hepatocytes | 96 |
7-Ketocholesterol Induces Protein Ubiquitination, Myelin Figure Formation, and Light Chain 3 Processing in Vascular Smooth Muscle Cells | 96 |
Cerivastatin, an Inhibitor of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase, Inhibits Endothelial Cell Proliferation Induced by Angiogenic Factors In Vitro and Angiogenesis in In Vivo Models | 96 |
Hypercholesterolemia in the Rabbit Induced by Feeding Graded Amounts of Low-Level Cholesterol | 96 |
Expansive Arterial Remodeling: Location, Location, Location | 95 |
Cytokines and Cell Adhesion Molecules in Cerebral Ischemia | 95 |
Both Intracellular and Extracellular Vitamin C Inhibit Atherogenic Modification of LDL by Human Vascular Endothelial Cells | 95 |
Role of Mitochondrial Permeability Transition Pore in Coated-Platelet Formation | 95 |
Endothelium-Dependent and -Independent Vasodilation of Large Arteries in Normoalbuminuric Insulin-Dependent Diabetes Mellitus | 95 |
Severe Periodontitis Enhances Macrophage Activation via Increased Serum Lipopolysaccharide | 95 |
17β-Estradiol Prevents Fatty Streak Formation in Apolipoprotein E–Deficient Mice | 95 |
Eplerenone With Valsartan Effectively Reduces Atherosclerotic Lesion by Attenuation of Oxidative Stress and Inflammation | 95 |
Oxidized LDL Can Induce Macrophage Survival, DNA Synthesis, and Enhanced Proliferative Response to CSF-1 and GM-CSF | 95 |
Serum Homocysteine and Risk of Coronary Heart Disease and Cerebrovascular Disease in Elderly Men | 95 |
Effects of Granulocyte Colony Stimulating Factor on Functional Activities of Endothelial Progenitor Cells in Patients With Chronic Ischemic Heart Disease | 95 |
Phenotypic Variation in Heterozygous Familial Hypercholesterolemia | 95 |
HDL
3
-Mediated Inhibition of Thrombin-Induced Platelet Aggregation and Fibrinogen Binding Occurs via Decreased Production of Phosphoinositide-Derived Second Messeng | 95 |
Signal-Crosstalk Between Rho/ROCK and c-Jun NH
2
-Terminal Kinase Mediates Migration of Vascular Smooth Muscle Cells Stimulated by Angiotensin II | 95 |
Lipoprotein Retention—and Clues for Atheroma Regression | 94 |
LDL Receptor–Related Protein Mediates Uptake of Aggregated LDL in Human Vascular Smooth Muscle Cells | 94 |
Lifestyle and Hemostatic Risk Factors for Ischemic Heart Disease | 94 |
Angiotensin II Stimulates the Release of Interleukin-6 and Interleukin-8 From Cultured Human Adipocytes by Activation of NF-κB | 94 |
Vitamin E Inhibits Low-Density Lipoprotein–Induced Adhesion of Monocytes to Human Aortic Endothelial Cells In Vitro | 94 |
Differential Expression of Chemokines, Risk of Stable Coronary Heart Disease, and Correlation with Established Cardiovascular Risk Markers | 94 |
Distribution in Healthy and Coronary Populations of the Methylenetetrahydrofolate Reductase (MTHFR) C
677
T Mutation | 94 |
Membrane Potential-Dependent Inhibition of Platelet Adhesion to Endothelial Cells by Epoxyeicosatrienoic Acids | 94 |
Lysosomal Enzymes Are Released From Cultured Human Macrophages, Hydrolyze LDL In Vitro, and Are Present Extracellularly in Human Atherosclerotic Lesions | 94 |
2-Chlorohexadecanal Derived From Hypochlorite-Modified High-Density Lipoprotein–Associated Plasmalogen Is a Natural Inhibitor of Endothelial Nitric Oxide Biosynthesis | 94 |
Prevalence and Correlates of Coronary Calcification in Black and White Young Adults | 94 |
Lipoprotein-Associated Phospholipase A
2
Is an Independent Marker for Coronary Endothelial Dysfunction in Humans | 94 |
Dysregulation of Monocytic Nuclear Factor-κB by Oxidized Low-Density Lipoprotein | 94 |
Haplotype-Specific Effects on Endothelial NO Synthase Promoter Efficiency | 93 |
Neutrophil, Not Macrophage, Infiltration Precedes Neointimal Thickening in Balloon-Injured Arteries | 93 |
Visceral Fat Accumulation and Its Relation to Plasma Hemostatic Factors in Healthy Men | 93 |
Pioglitazone Inhibits LOX-1 Expression in Human Coronary Artery Endothelial Cells by Reducing Intracellular Superoxide Radical Generation | 93 |
Altered Tetrahydrobiopterin Metabolism in Atherosclerosis | 93 |
Matrix Metalloproteinase-9 Genotype Influences Large Artery Stiffness Through Effects on Aortic Gene and Protein Expression | 93 |
Structural, Functional, and Hemodynamic Changes of the Common Carotid Artery With Age in Male Subjects | 93 |
Clinical Significance of Small Dense Low-Density Lipoprotein Cholesterol Levels Determined by the Simple Precipitation Method | 93 |
Smoking Impairs the Activity of Endothelial Nitric Oxide Synthase in Saphenous Vein | 93 |
Nonnuclear Actions of Estrogen | 92 |
Angiogenesis in Atherogenesis | 92 |
Mechanisms of Endothelial Differentiation in Embryonic Vasculogenesis | 92 |
Lipoprotein(a) in Homozygous Familial Hypercholesterolemia | 92 |
Neonatal Intima Formation in the Human Coronary Artery | 92 |
Mechanisms of Inducible Nitric Oxide Synthase–Mediated Vascular Dysfunction | 92 |
Mineralocorticoid Receptor Activation Promotes Vascular Cell Calcification | 92 |
HDL-Mediated Efflux of Intracellular Cholesterol Is Impaired in Fibroblasts From Tangier Disease Patients | 92 |
Cross-Sectional Study of Soluble Intercellular Adhesion Molecule-1 and Cardiovascular Risk Factors in Apparently Healthy Men | 92 |
A Simple Method of Plaque Rupture Induction in Apolipoprotein E–Deficient Mice | 92 |
Reduced Postprandial Serum Paraoxonase Activity After a Meal Rich in Used Cooking Fat | 92 |
Impaired Revascularization in a Mouse Model of Type 2 Diabetes Is Associated With Dysregulation of a Complex Angiogenic-Regulatory Network | 92 |
Immunological Evidence for the Presence of Advanced Glycosylation End Products in Atherosclerotic Lesions of Euglycemic Rabbits | 92 |
Differences in Insulin Suppression of Free Fatty Acid Levels by Gender and Glucose Tolerance Status | 92 |
Common and Rare
ABCA1
Variants Affecting Plasma HDL Cholesterol | 92 |
Analysis of Macrophage Scavenger Receptor (SR-A) Expression in Human Aortic Atherosclerotic Lesions | 92 |
Lipoprotein Response to Diets High in Soy or Animal Protein With and Without Isoflavones in Moderately Hypercholesterolemic Subjects | 92 |
Combination of Vitamins C and E Alters the Response to Coronary Balloon Injury in the Pig | 92 |
Serum Amyloid A and Lipoprotein Retention in Murine Models of Atherosclerosis | 92 |
Assembly of High-Density Lipoprotein | 91 |
Stimulated Tissue Plasminogen Activator Release as a Marker of Endothelial Function in Humans | 91 |
Oxidative Stress Promotes Endothelial Cell Apoptosis and Loss of Microvessels in the Spontaneously Hypertensive Rats | 91 |
Origin of Vascular Smooth Muscle Cells and the Role of Circulating Stem Cells in Transplant Arteriosclerosis | 91 |
Statin Protects Endothelial Nitric Oxide Synthase Activity in Hypoxia-Induced Pulmonary Hypertension | 91 |
Antibodies Against Oxidized LDL and Carotid Artery Intima-Media Thickness in a Healthy Population | 91 |
Recombinant Leptin Promotes Atherosclerosis and Thrombosis in Apolipoprotein E–Deficient Mice | 91 |
Mechanisms of Reactive Oxygen Species–Dependent Downregulation of Insulin Receptor Substrate-1 by Angiotensin II | 91 |
Fibronectin and Collagen I Matrixes Promote Calcification of Vascular Cells in Vitro, Whereas Collagen IV Matrix Is Inhibitory | 91 |
Chemokines and Incident Coronary Heart Disease | 91 |
Regulation of the Tissue Factor Gene in Human Monocytic Cells | 91 |
Chronic
Chlamydia pneumoniae
Infection Is Associated With a Serum Lipid Profile Known to Be a Risk Factor for Atherosclerosis | 91 |
Two Common, Functional Polymorphisms in the Promoter Region of the β-Fibrinogen Gene Contribute to Regulation of Plasma Fibrinogen Concentration | 91 |
Systemic Regulation of Vascular NAD(P)H Oxidase Activity and Nox Isoform Expression in Human Arteries and Veins | 91 |
Association of Lipoprotein-Associated Phospholipase A
2
Mass and Activity With Calcified Coronary Plaque in Young Adults | 91 |
Influence of
n-6
versus
n-3
Polyunsaturated Fatty Acids in Diets Low in Saturated Fatty Acids on Plasma Lipoproteins and Hemostatic Factor | 91 |
Role of ADP Receptor P2Y
12
in Platelet Adhesion and Thrombus Formation in Flowing Blood | 91 |
Role of cAMP Response Element Binding Protein in Cardiovascular Remodeling | 90 |
Plant Sterol-Fortified Orange Juice Effectively Lowers Cholesterol Levels in Mildly Hypercholesterolemic Healthy Individuals | 90 |
Expression of the VLDL Receptor in Endothelial Cells | 90 |
Smooth Muscle Cell Heterogeneity in Pulmonary and Systemic Vessels | 90 |
Dysfunction of Nitric Oxide Mediation in Isolated Rat Arterioles With Methionine Diet–Induced Hyperhomocysteinemia | 90 |
Oncostatin M Induces Angiogenesis In Vitro and In Vivo | 90 |
Apoptosis | 90 |
Increased Angiotensin II Type 1 Receptor Expression in Hypercholesterolemic Atherosclerosis in Rabbits | 90 |
Atherosclerosis, Vascular Remodeling, and Impairment of Endothelium-Dependent Relaxation in Genetically Altered Hyperlipidemic Mice | 90 |
Coronary Heart Disease: Reducing the Risk | 90 |
Estrogen Receptor β Protects the Murine Heart Against Left Ventricular Hypertrophy | 90 |
Intra-Arterial Tumor Necrosis Factor-α Impairs Endothelium-Dependent Vasodilatation and Stimulates Local Tissue Plasminogen Activator Release in Humans | 90 |
Basic Fibroblast Growth Factor–Induced Angiogenic Phenotype in Mouse Endothelium | 90 |
Dietary and Genetic Probes of Atherogenic Dyslipidemia | 89 |
Assessment of Unstable Atherosclerosis in Mice | 89 |
Macrophage-Specific p53 Expression Plays a Crucial Role in Atherosclerosis Development and Plaque Remodeling | 89 |
Genetics, Clinical Phenotype, and Molecular Cell Biology of Autosomal Recessive Hypercholesterolemia | 89 |
Inhibition of Vascular Smooth Muscle Cell Proliferation, Migration, and Survival by the Tumor Suppressor Protein PTEN | 89 |
Partial Off-Loading of Longitudinal Tension Induces Arterial Tortuosity | 89 |
Ultrastructure of Early Lipid Accumulation in ApoE-Deficient Mice | 89 |
Interferon-γ Induces Downregulation of Tangier Disease Gene (ATP-Binding-Cassette Transporter 1) in Macrophage-Derived Foam Cells | 89 |
Immunohistochemical Expression of Vascular Endothelial Growth Factor/Vascular Permeability Factor in Atherosclerotic Intimas of Human Coronary Arteries | 89 |
Human Vascular Smooth Muscle Cells Express Receptors for CC Chemokines | 89 |
ADAM17 Mediates Epidermal Growth Factor Receptor Transactivation and Vascular Smooth Muscle Cell Hypertrophy Induced by Angiotensin II | 89 |
Long-Term Inhibition of Rho-Kinase Suppresses Neointimal Formation After Stent Implantation in Porcine Coronary Arteries: Involvement of Multiple Mechanisms | 89 |
Granzyme B Induces Smooth Muscle Cell Apoptosis in the Absence of Perforin | 89 |
Fibrinogen and Silent Atherosclerosis in Subjects With Cardiovascular Risk Factors | 88 |
Thrombin Promotes Activation of Matrix Metalloproteinase-2 Produced by Cultured Vascular Smooth Muscle Cells | 88 |
Mildly Oxidized LDL Induces Platelet Aggregation Through Activation of Phospholipase A
2 | 88 |
Similarities and Differences in Smooth Muscle α-Actin Induction by TGF-β in Smooth Muscle Versus Non–Smooth Muscle Cells | 88 |
Asymmetric Dimethylarginine Increases Mononuclear Cell Adhesiveness in Hypercholesterolemic Humans | 88 |
Mast Cell Chymase Induces Smooth Muscle Cell Apoptosis by a Mechanism Involving Fibronectin Degradation and Disruption of Focal Adhesions | 88 |
Gallates Inhibit Cytokine-Induced Nuclear Translocation of NF-κB and Expression of Leukocyte Adhesion Molecules in Vascular Endothelial Cells | 88 |
Influence of PAI-1 on Adipose Tissue Growth and Metabolic Parameters in a Murine Model of Diet-Induced Obesity | 88 |
Quantitative and Qualitative Differences in Proatherogenic NKT Cells in Apolipoprotein E–Deficient Mice | 88 |
Cholesterol Enrichment of Human Monocyte/Macrophages Induces Surface Exposure of Phosphatidylserine and the Release of Biologically-Active Tissue Factor–Positive Microvesicles | 88 |
C-Peptide Colocalizes with Macrophages in Early Arteriosclerotic Lesions of Diabetic Subjects and Induces Monocyte Chemotaxis In Vitro | 88 |
No Effect of C-Reactive Protein on Early Atherosclerosis Development in Apolipoprotein E*3-Leiden/Human C-Reactive Protein Transgenic Mice | 88 |
In Vivo Plaque Characterization Using Intravascular Ultrasound–Virtual Histology in a Porcine Model of Complex Coronary Lesions | 88 |
Polymorphisms of the Human Matrix Gla Protein (
MGP
) Gene, Vascular Calcification, and Myocardial Infarction | 88 |
Histone Deacetylase Inhibitor Reduces Monocyte Adhesion to Endothelium Through the Suppression of Vascular Cell Adhesion Molecule-1 Expression | 88 |
A Negative Carotid Plaque Area Test Is Superior to Other Noninvasive Atherosclerosis Studies for Reducing the Likelihood of Having Underlying Significant Coronary Artery Disease | 88 |
Regulation of Human ApoA-I by Gemfibrozil and Fenofibrate Through Selective Peroxisome Proliferator-Activated Receptor α Modulation | 88 |